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Abstract: The purpose of the present study was to examine the effects of a normobaric 
intermittent hypoxic training (NIHT) intervention protocol, when compared to  
normobaric normoxia (NN)  training, on maximal aerobic endurance performance in both 
(NN) and hypobaric hypoxia (HH). Eleven male Reserve Officers’ Training Corps 
(ROTC) cadets (age 19.55 ± 1.44 y, mass 75.80  ± 8.82 kg, stature 177.45 ± 6.67 cm) 
completed the 6 week training intervention in either the NIHT (EXP, n = 6) or NN (CON, 
n = 5) conditions. Pre- and post-testing included assessments of peak oxygen uptake 
(VO2peak) in both NN and HH conditions with the NIHT group also completing a follow-
up VO2peak assessment after a 1 week detraining period. Participants also completed blood 
draws to assess any changes to the blood’s O2-carrying capacity. Mixed ANOVA was 
performed to analyze differences between the within-subjects factor (time) and between-
subjects factor (EXP and CON). Repeated measures ANOVA were also performed to 
analyze differences for all variables between the pre-, post-, and follow-up results of the 
EXP group. The present study revealed that NIHT failed to elicit greater aerobic 
endurance performance in either NN or HH conditions when compared to NN endurance 
training. Further, NIHT did not induce significant adaptations of the blood’s O2-carrying 
capacity compared to endurance training in normoxia. However, there was a significant 
main effect of time (P < .05) on endurance performance in the NN condition as 
demonstrated by a 5.44% increase in VO2peak. There was also a significant main effect of 
time (P < .01) on endurance performance in the HH condition as demonstrated by an 
11.48% increase in VO2peak. Further, there was also a significant interaction of time x 
training group (P < .05) for resting arterial O2 saturation as measured via pulse oximetry 
(SpO2) as a result of a 2.39% increase in SpO2 values for the EXP group and a 
simultaneous decrease of 2.72% in SpO2 values for the CON group from the pre- to post-
testing measurements conducted in the HH chamber. These findings may have critical 
relevance for military personnel conducting operations in high altitude locations.  
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CHAPTER I 
 
INTRODUCTION 
 
 French physiologist Claude Bernard is credited with being the first individual to 
observe the ability of the human body’s milieu intéieur, or internal environment, to 
maintain relative consistency within itself despite alterations in the external environment. 
In 1932, Walter Cannon introduced the term homeostasis to define this internal stability 
in his book The Wisdom of the Body, in which he went on to propose that certain 
physiological mechanisms exist in order to both preserve and restore homeostasis when 
challenged by deviations in either the internal or external states. The physiological 
mechanisms to which Cannon was referring would later come to be known as the 
feedforward and feedback systems (Fox, 1987). However, despite the human body’s 
capacity to maintain homeostasis, chronic exposure to external stimuli may prohibit a 
return to equilibrium even with the acute physiological responses. 
 Under such circumstances when an individual remains in a setting, i.e. 
environmental altitude, that elicits acute physiological responses in an attempt to 
maintain homeostasis, these short-term responses eventually give way to more permanent 
processes (Sherwood, 2011). The specific environmental stressor at altitude is the 
reduced availability of oxygen (O2) due to the decline in the partial pressure of O2 (PO2). 
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While the percentage of O2, which may also be referred to as the fraction of inspired O2 
(FiO2), is a constant at 20.9% at any elevation, as altitude increases, the barometric pressure 
(PB) decreases, resulting in a subsequent decline in PO2.  At sea level, PB is 760 mmHg, PO2 
is 158.84 mmHg (760 mmHg x 0.209), and arterial oxygen partial pressure (PaO2) is 100 
mmHg. For comparison, at an elevation of 10,000 ft, or 3048 m, PB is 522.7 mmHg, PO2 is 
109.24 mmHg (522.7 mmHg x 0.209), and PaO2 is 60 mmHg. Due to the reduced PB 
encountered in environmental altitude, an individual’s maximal aerobic capacity, or VO2max, 
is compromised, which in turn leads to a reduction in both endurance performance and the 
ability to recover between bouts of activity. Further, it has been shown that trained 
individuals display greater decreases in VO2max at moderate altitudes when compared to 
untrained individuals (Pascal Mollard et al., 2007). As VO2max is a product of multiple 
physiological systems related to O2 supply, transfer, delivery, and use, there are a number of 
adaptations, both acute and chronic, that may occur due to altitude acclimatization. These 
adaptations may lead to potential enhancements in aerobic capacity while at increased 
elevations (Ponsot et al., 2006).  
 Acute changes may include, but are not limited to, increased heart rate (HR) and 
increased breathing rate, both of which represent an effort to increase O2 availability to the 
body (Sherwood, 2011). The longer-term adaptations that typically occur after continued 
residence of 1-3 weeks (Martin Burtscher, 2005; Krueger, 1993; B. D. Levine, 2002; Muza, 
2007) at natural altitude are ordinarily categorized as either hematological or non-
hematological. Some of the  most highly researched hematological adaptations to altitude 
include, but are not limited to, increases in arterial oxygen saturation (SaO2), increased 
hemoglobin (Hb) concentration via increased erythropoietin (EPO) levels, and decreased 
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plasma volume (PV) (M Burtscher, Faulhaber, Flatz, Likar, & Nachbauer, 2006; Fulco, 
Beidleman, & Muza, 2013). Commonly examined and widely debated non-hematological 
adaptations to sustained stays at altitude are improvements in the efficiency of movement and 
muscle buffering capacity (Cheung, 2010; B. D. Levine & Stray-Gundersen, 2005). Current 
guidelines for acclimatization recommend ascents at a rate of 300-600 m per day (Krueger, 
1993; Muza, 2007) and although acclimatization occurs over a lengthier time period than the 
onset of physiological adjustments to acute altitude exposure, these modifications are more 
enduring, but not necessarily permanent (Beidleman et al., 1997; Muza, Beidleman, & Fulco, 
2010).  
 In 1963 the International Olympic Committee (IOC) awarded the 1968 Summer 
Olympics to Mexico City. Due to Mexico City’s elevation (2250 m), there was an increase in 
research efforts investigating the potential benefits of training at elevation and subsequent 
impact on athletic performance at altitude as well as sea level.  Despite the escalation in 
research efforts following the IOC’s decision (Daniels, 1979), significant findings in this 
field had already been made prior to 1963. However, the majority of the aforementioned 
research had concerned itself with either high altitude residents or mountaineering 
expeditions, with little to no regard for the relationship between elite athletic competition and 
altitude. Further, these early inquiries led some investigators to begin examining the practice 
of discontinuous exposure for altitude acclimation (Stickney & Van Liere, 1953; Van Liere, 
1943), the process now referred to as intermittent hypoxic training (IHT). Fueled by the 
participating nations’ desire for Olympic glory and founded on the results of the preliminary 
investigations, the field of altitude training and associated research expanded to bring about 
numerous philosophies.  
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 The original altitude training strategy included Live High-Train High (LHTH), 
wherein the athletes would both live and train in mountainous locales. More modern training 
protocols include Live High-Train Low (LHTL), where the athletes reside in natural or 
simulated altitudes and train in low-altitude settings, and Live Low-Train High (LLTH), in 
which individuals live in low altitude settings and train in simulated altitude conditions. 
While the advancements in this field may have been accelerated in preparation for the 1968 
Mexico City Olympic Games, these same techniques have been adopted by elite athletes 
seeking a competitive advantage when competing not only at altitude, but also at low 
elevation contests (Gregoire P Millet, Roels, Schmitt, Woorons, & Richalet, 2010). Though it 
should be noted that each of the aforementioned altitude training methods are still being 
employed today, LHTL has gained the most notoriety based on both anecdotal and research-
based evidence; however, much of the benefit of LHTL is observed during endurance 
performance at or near sea level (SL) (Wilber, 2007b). Further, the LLTH strategy, along 
with the development of simulated altitude technologies utilizing both hypobaric hypoxia 
(HH), a state in which ambient PO2 is lowered through a decrease in PB, and normobaric 
hypoxia (NH), a state in which FiO2 is decreased via an increase in the percentage of 
nitrogen (N2) in ambient air, has born about two additional acclimation strategies, 
intermittent hypoxic exposure (IHE) and the previously mentioned IHT. IHT exposes the 
user to brief periods of hypoxic conditions, typically 1-2 h in length and is performed while 
the user is exercising, allowing them to live in low elevation locations and train at higher 
elevation (Krueger, 1993; Powell & Garcia, 2000). However, despite the growth and new 
ideas, there still remains speculation concerning the best practices and application for altitude 
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training, specifically, the efficacy of IHT to improve performance at moderate and high 
altitudes. 
Statement of Problem 
 Presently, the United States (U.S.) military finds itself in a transition period. As a 
result of limited financial resources, when compared to past defense budgets, and a 
transforming geo-political climate, an ambiguous future awaits (Braun III & Allen, 2014). 
Additionally, the U.S. national defense strategy is influenced both by the actions and 
decisions of not only enemies, but also American allies (Laird, Timperlake, & Delaporte, 
2014).  However, despite these limitations, the U.S. military must maintain combat readiness 
at all times. Whether it be in times of peace, preparing to face enemies of the state, or 
assisting allies in joint military endeavors, U.S. armed forces attempt to maintain peak 
readiness at all times. Recent and current events have led to military personnel deployments 
to locations in the Middle East; locales that place additional physiological burdens related to 
extreme environments such as high altitude on personnel (Nindl et al., 2013). For instance, 
Afghanistan has several mountain passes with elevations exceeding 3000 m. Severe 
environmental conditions pose additional threats to the health of soldiers and their ability to 
carry out missions. Specifically, operations conducted at high altitude will increase the 
relative workload for personnel and unacclimatized soldiers may suffer from acute mountain 
sickness (AMS) or more severe forms of AMS such as high-altitude cerebral edema (HACE) 
or high-altitude pulmonary edema (HAPE), both of which may be life-threatening (Krueger, 
1993; Muza, 2007; Nindl et al., 2013). Further, prior investigations have reported significant 
mental detriments in the form of increased mood states such as anger and fatigue in soldiers 
completing high-altitude field training exercises (Bardwell, Ensign, & Mills, 2005).  
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Therefore, it is imperative that all potentially beneficial options to prepare soldiers for high 
altitude operations should be explored. However, the majority of studies examining the 
effects of the various methods of altitude training focus on elite level athletes, with the lion’s 
share of the aforementioned work concentrating on performance at elevations at or near sea 
level. Consequently, researching the potential implications of simulated altitude training on 
the performance of military personnel at altitude is of increasing importance. 
 However, multiple altitude acclimatization, or adaptations brought about by exposure 
to terrestrial altitude, and acclimation, or adaptations induced via exposure to simulated 
altitude, methods exist, each with their own advantages and disadvantages in regards to 
efficacy, accessibility, and costs (Beidleman, Fulco, Staab, Andrew, & Muza, 2014; Cheung, 
2010; B. D. Levine, 2002; Gregoire P Millet et al., 2010). Therefore, this investigation 
attempts to provide greater insight regarding the potential efficacy of normobaric IHT 
(NIHT) to elicit both hematological and non-hematological adaptations, as well as 
performance enhancements when testing under HH conditions. Specifically, the questions 
that have been attempted to be answered within this investigation are: 1) Is the prescribed 
NIHT training volume of 18 h over a period of 6 weeks sufficient to elicit significant 
hematological changes within the experimental (EXP) group when compared to the control 
(CON) group? 2) Is NIHT effective at improving VO2max in an HH setting? 3) 4) If NIHT 
does produce significant physiological changes, how similar, it at all, are said changes to 
those previously identified using hypobaric IHT (HIHT) research designs?  5) If there were 
any significant hematological and/or nonhematological adaptations as a result of NIHT, will 
follow-up testing following a detraining period of 2 weeks demonstrate any resiliency of said 
alterations? 
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Rationale 
 Environmental conditions have impacted the outcome of military endeavors as long 
as there has been war, and while progress continues to be made in minimizing the effects of 
altitude on soldier health and performance, there remains room for improvement (Nindl et al., 
2013). To date, there have been significant efforts, and tangible gains, to alleviate the 
occurrence of AMS in soldiers through acclimatization efforts utilizing simulated altitude via 
both NH and HH (Beidleman et al., 2014; Raphael Faiss et al., 2013; Feriche et al., 2014; 
Fulco et al., 2011; Neya, Enoki, Kumai, Sugoh, & Kawahara, 2007; Ponsot et al., 2006; 
Richard & Koehle, 2012; Schommer et al., 2010). However, as sustained combat operations 
often consist of endurance activities consisting of low to high intensity periods of work 
(Henning, Park, & Kim, 2011), combined with the evidence that both submaximal and 
maximal endurance capabilities are significantly diminished even at altitudes of 1500-2500 
m (Fulco et al., 2013; Muza, 2007; Muza et al., 2010), research efforts should continue to 
investigate possible means of improving soldiers’ aerobic capacity at altitude. The primary 
concern of any efforts to improve soldier performance at altitude is and must remain the 
efficacy of said training.  
 However, as has been previously mentioned, the U.S. national defense budget 
remains an area of contention, thus the financial feasibility of such endeavors must be 
considered. Further, other considerations such as relocation, travel, and ease of 
implementation should also be taken into account when attempting to select the most 
appropriate acclimatization effort. That being said, this paper does not dispute the disparity 
that has been reported between NH and HH (Beidleman et al., 2014; Dufour et al., 2006; 
Raphael Faiss et al., 2013; Feriche et al., 2014; Fulco et al., 2011; Richard & Koehle, 2012). 
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Yet, as Muza (2007) noted, much of the prior research has utilized hypobaric chambers, 
which are not readily accessible for military personnel use. Further, hypobaric chambers are 
not only extremely expensive in terms of financial cost, but also require skilled technicians to 
maintain and operate as well as the presence of registered nurses (RN) and medical doctors 
when in use, all of which add to the effective cost of usage.  
 IHT utilizing NH equipment is one potential method that would serve to be more 
economically feasible than hypobaric chambers, as well as more user friendly and convenient 
for military personnel. Additionally, while HH has been shown to be superior to NH in terms 
of generating acclimation to environmental altitude (Beidleman et al., 2014; Raphael Faiss et 
al., 2013; Feriche et al., 2014; Fulco et al., 2011; Richard & Koehle, 2012), there is evidence 
that NH does enhance acclimation to altitude, as well as stimulate other physiological 
adaptations considered beneficial for performance in natural altitude settings (Dufour et al., 
2006; Geiser et al., 2001; Mackenzie, Watt, & Maxwell, 2008; Vogt et al., 2001). Based on 
prior research efforts, it does appear reasonable to believe that NIHT has the potential to be 
an effective altitude acclimation strategy for military personnel in terms of physical 
performance, financial cost, and accessibility. Due to the target population, even if significant 
changes are not induced as a result of the NIHT training protocol, any enhancements in 
soldier endurance performance at altitude would be of importance as the smallest increases in 
performance may lessen the impact of the challenges triggered during combat operations in 
high altitude settings (Henning et al., 2011; Krueger, 1993; Nindl et al., 2013). Therefore, 
further research such as the current investigation is justifiable in an effort to add to the 
discussion of NIHT’s efficacy and applicability when attempting to prepare soldiers for 
deployments to mountainous locales. 
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Statement of Purpose 
 The purpose of the present study was to examine the effects of 6 weeks of NIHT on 
erythrocyte (RBC) volume, hemoglobin (Hb) levels, hematocrit (Hct) levels, serum 
erythropoietin (EPO) production, and maximal aerobic endurance performance both in 
normoxic and hypobaric hypoxic conditions when compared to normoxic training in ROTC 
cadets.  
Hypotheses 
 
1. H0: There will be no difference in erythrocyte (RBC) volume percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
        
       HA: The EXP group will demonstrate a significantly greater RBC volume  
       percent change compared to the CON group upon completion of the 6 week 
  intervention training period. 
 
2. H0: There will be no difference in the hemoglobin (Hb) level percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
       
       HA: The EXP group will demonstrate a significantly greater Hb level    
        percent change compared to the CON group upon completion of the 6 week 
   intervention training period. 
 
3. H0: There will be no difference in the hematocrit (Hct) level percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
       
       HA: The EXP group will demonstrate a significantly greater Hct level percent   
        change compared to the CON group upon completion of the 6 week  
  intervention training period. 
 
4. H0: There will be no difference in serum erythropoietin (EPO) level percent 
 change between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
        
       HA: The EXP group will demonstrate a significantly greater serum EPO level  
        percent change compared to the CON group upon completion of the 6 week 
   intervention training period. 
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5. H0: There will be no difference in the time-to-exhaustion (TE) percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
HA: There will be a significant difference in the TE percent change between the 
 EXP and CON groups upon completion of the 6 week intervention training 
 period. 
 
6. H0: There will be no difference in the peak oxygen uptake (VO2peak) percent 
 change between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
      HA: There will be a significant difference in the VO2peak percent change            
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
7. H0: There will be no difference in the relative peak oxygen uptake (RVO2peak) 
 percent change between the EXP and CON groups upon completion of the 6 
 week intervention training period. 
 
      HA: There will be a significant difference in the RVO2peak percent change            
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
8. H0: There will be no difference in the minute ventilation (VE) percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
HA: There will be a significant difference in the VE percent change between the 
 EXP and CON groups upon completion of the 6 week intervention training 
 period. 
 
9. H0: There will be no difference in the respiratory frequency (f) percent change 
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
      HA: There will be a significant difference in f percent change between the EXP 
 and CON groups upon completion of the 6 week intervention training period. 
 
10. H0: There will be no difference in the tidal volume (Vt) percent change between 
 the EXP and CON groups upon completion of the 6 week intervention training 
 period. 
 
      HA: There will be a significant difference in the Vt percent change between the          
 EXP and CON groups upon completion of the 6 week intervention  training 
 period. 
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11. H0: There will be no difference in the end-tidal pressure of O2 (PetO2) percent 
 change between the EXP and  CON groups upon completion of the 6 week 
 intervention training period. 
 
      HA: There will be a significant difference in the PetO2 percent change            
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
12. H0: There will be no difference in the end-tidal pressure of CO2 (PetCO2) 
 percent change between the EXP and CON groups upon completion of the 6 
 week intervention training period. 
 
      HA: There will be a significant difference in the PetCO2 percent change            
 between the EXP and CON groups upon completion of the 6 week 
 intervention training period. 
 
Definition of Terms 
 
Acclimation: Adaptive physiological responses to experimentally induced changes in 
particular climate factors 
 
Acclimatization: Physiological adjustments brought about through chronic exposure to a 
different environment 
 
Acute: Short-term  
 
Acute mountain sickness: A syndrome characterized by headache, anorexia, nausea, 
vomiting, insomnia, lassitude, and malaise 
 
Adaptation: Changes to the human system induced by exposure to an environmental stressor 
 
Aerobic capacity: Highest rate at which an individual can consume and utilize O2 from the air 
 
Anoxia: An absence of O2 
 
Barometric pressure: The pressure exerted by the weight of the air in the atmosphere on 
objects on Earth’s surface 
 
Chronic: Long-term; continuing over time 
 
Deacclimatization: Process involving the loss of high-altitude acclimatization upon return 
from environmental altitude including, but not limited to, hematologic, respiratory, 
cardiovascular, and nervous systems 
 
Extreme altitude: 5500-8850 m (18,045-29,035 ft) 
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Hematological: Of, or related to, blood 
 
High altitude: 1500-3500 m (4921-11,483 ft) 
 
High altitude cerebral edema: A potentially fatal complication of acute mountain sickness; 
symptoms may include confusion, ataxia of gait, unconsciousness, and/or coma  
 
High altitude pulmonary edema: A potentially fatal complication of acute mountain sickness; 
symptoms may include excessive pulmonary vasoconstriction and/or pulmonary 
hypertension 
 
Homeostasis: Maintenance of a relatively stable internal environment 
 
Hypercapnia: Above-normal CO2 levels in arterial blood 
 
Hyperventilation: Increased pulmonary ventilation in excess of metabolic demands 
 
Hypobaric hypoxia: A state in which PO2 is lowered through a decrease in barometric 
pressure 
 
Hypocapnia: Below-normal CO2 levels in arterial blood 
 
Hypoxia: Condition of having insufficient O2 at the cellular level 
 
Intermittent hypoxic exposure: Discontinuous use of hypoxia, either hypobaric or 
normobaric, in a passive, resting state 
 
Intermittent hypoxic training: Discontinuous use of hypoxia, either hypobaric or normobaric, 
in an exercise training setting 
 
Live High-Train High: The practice of residing and performing exercise training at a 
moderate elevation, typically greater than 1500 m, for multiple weeks 
 
Live High-Train Low: The practice of residing at moderate elevations, typically 2000-2700 
m, for at least 8-10 h each day and performing exercise training at elevations less than  
1000 m 
 
Live Low-Train High: The practice of employing hypoxia during exercise training while 
individuals reside in normoxia  
 
Low altitude: 500-1500 m (1640-4921 ft) 
 
Normobaric hypoxia: A state in which PO2 is lowered through a decrease in the fraction of 
inspired oxygen 
 
Normoxia: The partial pressure of O2 in the inspired gas is equal to that of air at sea level 
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Sea level: 0-500 m (0-1640 ft) 
 
Stressor: Any stimulus that tends to disturb an individual’s homeostasis 
 
Very high altitude: 3500-5500 m (11,483-18,045 ft) 
 
Assumptions 
 
1. The samples are normally distributed and representative of their respective 
populations. 
2. Participants’ responses to the health history questionnaire were accurate and valid. 
3. All participants gave a maximal effort during all testing and training sessions. 
4. The equipment is appropriately calibrated and functioning properly. 
5. That there were no data collection, data analyses, data entry, nor statistical processing 
errors. 
Limitations 
  
1. Differences in the participants’ diets both between and within the groups may have 
had an effect on the responses to the training intervention. 
2. Differences in the participants’ sleeping habits both between and within the groups 
may have had an effect on the responses to the training intervention.  
3. Participants were only provided a HR range within which to keep their HR during the 
different portions of each training session, therefore, differences in motivation levels 
between participants may have had an effect on the response to the training 
intervention protocol both between and within groups.  
4. While there was no significant difference in total time in min exercising outside of the 
training intervention protocol between the EXP and CON groups (p > .05), 
differences in the participants’ exercise training intensity outside of the intervention 
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training protocol both between and within the groups may have had an effect on the 
responses to the training intervention.  
Delimitations 
 
 This study was delimited to Reserve Officers’ Training Corps (ROTC) cadets 
between the ages of 18-22 years of age. Additionally, all participants were required to be 
male and highly trained as determined by their initial VO2max. 
 This study was carried out in a single-blind manner in an attempt to minimize or 
eliminate the risk of the nocebo effect. All participants wore nearly identical training masks 
during all training sessions so as to inhibit the ability of participants to determine whether 
they were in the EXP or CON groups based on their training sessions.  
 In an attempt to increase the applicability of this investigation’s results to current 
military personnel, this study was designed to utilize the NIHT sessions as complementary 
exercise training and not the sole form of exercise training for the ROTC cadets. This 
strategy allowed for ROTC cadets to continue performing high-intensity exercise training 
during PT while also receiving the supplementary NIHT sessions. This is of importance as a 
common drawback of only using NIHT is the decreased intensity with which individuals are 
able to perform during training, thus, potentially offsetting any benefits that may have been 
derived as a result of the NIHT. Further, all training sessions were conducted at 
approximately the same time of day for each participant, thus attempting to minimize any 
diurnal variations between training sessions.
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CHAPTER II 
 
REVIEW OF LITERATURE 
 The purpose of this review of literature is to present and integrate the existing and 
relevant research in the areas of human acclimatization and acclimation to environmental 
and synthetic hypoxia, respectively. Further, the influence of acclimatization and 
acclimation efforts to enhance aerobic endurance performance in hypoxic settings  will 
also be scrutinized.   
Physiological Responses to Hypoxic Exposure 
 Acute exposure to altitude, whether it be environmental or simulated, brings about 
a number of immediate physiological responses in order to adapt to the decreased 
ambient PO2. This reduction in PO2 results in declines in inspired PO2 (PiO2), alveolar 
PO2 (PAO2), PaO2, and SaO2. These detriments ultimately lead to hypoxemia at the 
cellular level, stimulating the general response to the decreased availability of O2 
(Gallagher & Hackett, 2004). While there are a number of physiological adjustments in 
response to high altitude exposure, see Figure 1 developed by Peter Bärtsch and Gibbs 
(2007), only those related to the focus of this investigation will be discussed. These 
specific adaptations include increased ventilation, the stimulation for EPO production and 
release, and alterations in cardiac output (CO) as a result of adjustments in HR and stroke 
volume (SV), and finally, the impact of said adaptations on aerobic endurance 
performance.  
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Figure 1. Cardiovascular responses to acute hypoxic exposure (Peter Bärtsch & Gibbs, 
2007)  
 Upon continued exposure, further adjustments occur and include hematological 
changes such as a decrease in plasma volume, resulting in an increase in the relative 
levels of Hb and Hct. The rate and significance of the aforementioned changes are 
relative to the level of hypoxia to which one is exposed and continue to occur until one 
becomes acclimatized (Note: “acclimatization” will be used to indicate both 
acclimatization and acclimation in regards to adaptations brought about by exposure to 
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natural and simulated environments, respectively) to the severity of the respective decline 
in PO2 (S. A. Gallagher & Hackett, 2004). Sojourns to high altitude locales lasting more 
than 2-3 d require the human body to employ more enduring adjustments to the reduced 
PB and ambient PO2. The purpose of such undertakings is to curtail the effects of hypoxia 
in an attempt to restore some level of homeostasis for every organ system affected by the 
change in O2 availability. Together, these developments that take place remain to be fully 
understood. Adding to the difficulty of the development of a true comprehension of 
acclimatization is the inter-individual variability of responses to continued or repeated 
exposure to reductions of PO2 (Hennis, O’Doherty, Levett, Grocott, & Montgomery, 
2015). Yet, with adequate exposure, most humans are capable of becoming acclimatized 
to altitudes as high as 5500 m (S. A. Gallagher & Hackett, 2004). While the amount of 
time to be considered adequate may differ among individuals, the majority of prior 
studies seem to agree that 1-3 wk is typically sufficient for acclimatization to take effect 
(Fulco et al., 2013; Fulco, Rock, & Cymerman, 1998; Muza, 2007; Muza et al., 2010).   
 However, despite the almost immediate onset of physiological adjustments, the 
risk of adverse health effects upon initial introduction to altitude remains. One of the 
more common dangers of acute altitude exposure is the development of an high-altitude 
illness. High-altitude illness is used to describe three conditions brought about by acute 
exposure to a reduction in ambient PO2, AMS, HACE, and HAPE, the latter two of which 
can be fatal. For example, it has been reported that 8% of casualties suffered during the 
initial 9 months of Operation Enduring Freedom in Afghanistan resulted from cases of 
high-altitude illness (Tannheimer et al., 2009). Further, the risk for each of the 
aforementioned conditions depends not only on individual variabilities but also the 
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variables specific to each ascent such as ascent rate, destination altitude, base camp level 
or altitude at which one sleeps, exposure duration, physical exertion level, ambient 
temperature and PB, altitude of residence and/or acclimatization efforts prior to initial 
ascent, pre-existing conditions and associated medications, and personal history of high-
altitude illness development, if any (Fulco et al., 2013; S. A. Gallagher & Hackett, 2004; 
Muza, 2007).  
 AMS has the greatest occurrence rate of the high-altitude illnesses with prior 
research reporting such rates ranging from approximately 10-90% globally. This 
extensive range is due to the wide array of variables that impact the onset of AMS, with 
symptoms typically arising approximately 6-10 h after exposure and may present as early 
as 1 h after initial exposure (Richard et al., 2014) as well as variations in the 
methodologies used to conduct the aforementioned research (S. A. Gallagher & Hackett, 
2004).  Initial symptoms of AMS typically include headaches, nausea, decreased hunger, 
dizziness, inability to sleep, and increased feelings of fatigue, with more severe cases of 
AMS displaying increased intensity of the aforementioned symptoms as well the 
potential for vomiting. Undiagnosed or untreated cases of AMS may progress to either 
HACE or HAPE, which is amplified if the affected individual continues to ascend to 
higher elevations without a sufficient acclimatization period (S. A. Gallagher & Hackett, 
2004; Norris et al., 2012; Schommer, Menold, Subudhi, & Bärtsch, 2012).  
 It is widely accepted that continuous residence at high altitude leads to altitude 
acclimatization, thus reducing and potentially eliminating the risk of AMS; yet, the risk 
of high-altitude illness is still present upon the initial exposure during preacclimatization 
efforts and returns upon ascent to a greater elevation than the one at which the individual 
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had become acclimatized (Fulco et al., 2013; Muza, 2007; Muza et al., 2010). Further, 
there is emerging evidence that intermittent exposure to simulated altitude may reduce 
the risk of AMS, however, while these results have demonstrated a decrease in the risk 
for AMS, each study has reported varying degrees of efficacy, likely due to both the 
severity of hypoxia utilized and the individual variability present in AMS cases 
(Beidleman et al., 2004; M Burtscher, Brandstätter, & Gatterer, 2008; Fulco et al., 2013; 
Muza, 2007). Additionally, prior research has demonstrated that AMS symptoms are 
more severe in HH than NH at equivalent PO2 levels. Based on these previous results, 
utilization of HH, when compared to NH, during acclimatization efforts has been shown 
to be more likely to achieve preacclimatization for exposure to terrestrial altitude (Fulco 
et al., 2011; Richard et al., 2014; R. C. Roach, Loeppky, & Icenogle, 1996; Schommer et 
al., 2010). 
 High-altitude illnesses, including AMS, HAPE, and HACE, display their most 
severe symptoms between 24-48 h (Fulco et al., 2013) but individuals may remain 
susceptible up to 3-5 d (S. A. Gallagher & Hackett, 2004) after initial exposure to 
altitudes greater than 2500 m. The persistence of symptoms beyond these time periods 
may suggest a diagnosis other than an high-altitude illness or signal the necessity for 
treatments to diminish symptoms including immediate descent of at least 1000 m, 
provision of O2 to elicit an SaO2 of at least 90%; in more severe cases such as HAPE and 
HACE, medications, if available, may be necessary (Fulco et al., 2013; S. A. Gallagher & 
Hackett, 2004; Muza et al., 2010; Norris et al., 2012). Due to the time lag between initial 
exposure and the onset of high-altitude illness symptoms, individuals attempting to 
perform rapid ascents may subject themselves to greater risk of HACE and HAPE. The 
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aforementioned circumstance is of particular concern for military personnel who are 
often required to make rapid ascents with no opportunity to descend if symptoms do 
occur (Tannheimer et al., 2009). Further, risk of illness is intensified as such operations 
require soldiers to perform strenuous work (R. Roach et al., 2000).  
Continuous exposure, and/or gradual ascents, to altitude remain the most 
successful strategies to alleviate any high-altitude illness symptoms an individual may 
experience. However, as previously mentioned, there is emerging evidence that pre-
acclimatization strategies employing intermittent, simulated altitude exposures may be 
adequate to prevent or minimize the effects of AMS and its more severe forms 
(Beidleman et al., 2004; M Burtscher et al., 2008; Fulco et al., 2013; Muza, 2007). There 
remain questions to be answered regarding the efficacy of such acclimatization strategies; 
nevertheless, two trends for acclimatization practices have emerged. First, multiple works 
have demonstrated the greater efficacy of HH, utilizing both objective and subjective 
measures, to prevent and minimize AMS symptoms (Fulco et al., 2011; Richard et al., 
2014; R. C. Roach et al., 1996; Schommer et al., 2010). Second, in a 2010 review by 
Muza and colleagues, minimum standards for altitude severity and exposure time to 
induce acclimatization were proposed; in regards to continuous exposure, 6 d of 
continuous residence at 2200 m decreased risk of AMS and enhanced performance when 
participants were subjected to 4300 m. Further, prior investigations utilizing altitudes 
greater than 3000 m, combined with exposure durations of 5 d or more, have reported 
that such acclimatization strategies preceding sojourns to elevations greater than 4500 m 
significantly reduced AMS prevalence. Additionally, the perseverance of acclimatization 
appears to be correlated to the level of acclimatization achieved as acclimatization 
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significantly diminishes approximately 3 d after returning to low altitude for less 
acclimatized persons and after 7 d for more acclimatized individuals (Muza et al., 2010).  
 It is well documented that one of the more immediate physiological responses to a 
decrease in PiO2 and ensuing hypoxemia is a change in ventilation. The subsequent 
commencement of hyperventilation typically occurs after an introduction to altitudes 
above 1500 m, whether terrestrial or synthetic. This adaptation, which can occur within 
minutes of altitude exposure, is referred to as the hypoxic ventilatory response (HVR) 
and leads to a nearly instantaneous decrease in alveolar PCO2 (PACO2) and an increase in 
both PAO2 and SaO2, although there is considerable inter-individual variation in HVR 
(Chapman, Stray-Gundersen, & Levine, 1998; Fulco et al., 2013; S. A. Gallagher & 
Hackett, 2004). Individuals with a more pronounced HVR are referred to as responders 
and those with a lower HVR are classified as non-responders. Evidence suggests that 
responders display decreased risk and severity of symptoms of high-altitude illnesses, 
with the opposite true for non-responders (Chapman et al., 1998). In addition to research-
based evidence of the differences between responders and non-responders, anecdotal 
evidence exists in mountaineering as some climbers require supplemental O2 to complete 
ascents of moderate to high peaks while other climbers are capable of completing the 
ascents by breathing only ambient air (Michael J Hamlin, Draper, & Hellemans, 2013). 
Multiple works utilizing healthy, but not trained, individuals reported significant changes 
in at least one of the following ventilatory variables of minute ventilation (VE), tidal 
volume of ventilation (Vt), and breathing frequency (f) (M Burtscher et al., 2008; Raphael 
Faiss et al., 2013; S. A. Gallagher & Hackett, 2004; Loeppky et al., 1997; Muza et al., 
2010; Sharma & Brown, 2007). Furthermore, the HVR may be altered by the 
22 
 
consumption of foods or medications containing respiratory stimulants or depressants (S. 
A. Gallagher & Hackett, 2004).  
 Additionally, and of particular note for the current investigation, is the difference 
in the HVR between HH and NH environments that has been reported in multiple works 
(Raphael Faiss et al., 2013; Hemmingsson & Linnarsson, 2009; Loeppky et al., 1997; 
Grégoire P Millet, Faiss, & Pialoux, 2012; Savourey, Launay, Besnard, Guinet, & 
Travers, 2003). Investigations performed by Loeppky et al. (1997) and Faiss et al. (2013) 
described similar results in that each study displayed comparable increases for VE in both 
HH and NH settings within the initial hour of exposure; however, after continued 
exposure, VE in the HH condition declined whereas VE in the NH condition remained 
elevated, leading to the significant differences between the two conditions. Furthering the 
evidence of the different physiological responses to acute exposure of HH and NH 
settings is the difference in VT. Faiss et al. (2013) described significantly reduced VT 
levels in HH compared to NH beginning 8 h after introduction to the respective hypoxic 
conditions corresponding to 3000 m and continuing through the remainder of the 24 h 
experiment. Savourey et al. (2003), utilizing a PO2 equivalent to 4500 m, reported 
significantly lower VT and greater f during the HH condition compared to the NH 
condition. These variances presented during only a 40 min exposure, implying more 
shallow breathing may occur rather quickly upon exposure to HH. Loeppky et al. (1997) 
detailed similar, although not significant, increases of VT during 9 h of NH exposure, 
FiO2 = 14.2%, compared to HH exposure, PB = 432.  
 Moreover, there is sufficient evidence that aerobic exercise exacerbates the 
differences in VE between normoxic and hypoxic conditions. Authors investigating 
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changes in VE under multiple FiO2 values during graded exercise tests (GXT) performed 
on a treadmill revealed significant increases in VE during the hypoxic condition, FiO2 = 
17%, compared to both the normoxic and hyperoxic conditions, FiO2 = 21% and 66%, 
respectively (Mateika & Duffin, 1994). Later inquiries demonstrated pronounced 
increases in VE throughout stationary cycling incremental exercise tests performed in 
normoxic (FiO2 = 21%) and two NH conditions (FiO2 = 15%, 12%), with differences 
reported between the normoxic and both hypoxic conditions as well as a significant 
increase in VE from the mild to moderate hypoxic condition. Likewise, during the same 
inquiry, the authors also reported a significant escalation in VE during moderate steady 
state exercise from the normoxic to moderate hypoxic conditions but not between the 
normoxic and mild hypoxic conditions (Engelen et al., 1996). However, more recent 
research reported no differences in VE neither during nor after maximal exertion treadmill 
running tests completed at 2800 m and 180 m (Stang, Bråten, Caspersen, Thorsen, & 
Stensrud, 2014).  
 As previously mentioned, the HVR occurs rather rapidly in response to reductions 
of PO2 and subsequent cellular hypoxemia. The HVR continues to occur until an 
individual becomes fully acclimatized to the corresponding severity of altitude to which 
they have been exposed, either through continuous residence or repeated exposure. From 
the initiation of the HVR, VE continues to increase for approximately 1-2 wk (P Bärtsch 
& Saltin, 2008; Fulco et al., 2013; S. A. Gallagher & Hackett, 2004). While the HVR 
leads to ventilatory acclimatization that nearly restores PAO2, PaO2, PCO2, and other 
markers of gas exchange to their respective SL equivalents within a relatively short 
period, prior works have shown that exposures lasting multiple years continue to increase 
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the HVR compared to shorter stays, which tends to support the idea that a direct 
relationship between length of stay and level of HVR does indeed exist (Fulco et al., 
2013).   
Beyond the HVR, altitude exposure leads to hematological adjustments in an 
attempt to counter the decreased PO2 and subsequently lower PaO2, which lead to a series 
of regulatory devices that attempt to restore the PaO2 to homeostatic levels. The earliest 
of these responses is the secretion of EPO. Renal peritubular cells, which are sensitive to 
PO2 levels within the body, signal the production and release of EPO from the kidneys 
(Mackenzie et al., 2008; Rasmussen, Siebenmann, Diaz Molina, & Lundby, 2013). This 
process is controlled by the O2-regulated EPO genetic transcription, which is controlled 
by the hypoxia-inducible factor-1 (HIF-1). During normoxia, HIF-1, which is present in 
all tissues, has a half-life of approximately 5 min, but under hypoxic cellular conditions, 
the HIF-1 half-life increases to roughly 30 min. This increase in the stability of HIF-1 is 
ultimately responsible for the EPO response, and numerous other physiological 
responses, to hypoxic conditions, thus, HIF-1 may provide a potential genetic explanation 
for the large inter-individual response to hypoxia (Christopher John Gore, Clark, & 
Saunders, 2007; Rusko, Tikkanen, & Peltonen, 2004; Semenza, 2000). 
In one of the earlier works investigating the regulation of EPO in humans exposed 
to acute altitude, results demonstrated the relationship between both the severity of 
altitude and total exposure time and the ensuing release of EPO. The investigators 
revealed that significant increases in serum EPO levels occurred after only 114 and 84 
min of HH exposure at simulated altitudes equitable to 3000 m and 4000 m, respectively 
(Eckardt et al., 1989). Since that time, a number of studies have yielded similar 
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relationships between the altitude severity, time course of exposure, and EPO release, as 
evidenced in multiple reviews. However, as is noted in said reviews, while there does 
appear to be growing consensus regarding the magnitude of the decrease in ambient PO2 
and the minimal exposure time necessary to induce EPO secretion, there have also been 
various works reporting conflicting results (Ge et al., 2002; B. D. Levine, 2002; 
Mackenzie et al., 2008). However, there does appear to be some consensus amongst the 
various investigations. First, the minimal altitude required to elicit an increase in serum 
EPO appears to be approximately 2000 m. Second, a duration of at least 2 h is required to 
stimulate EPO production and release. One potential reason for the contrasting results is 
the differences in methodologies utilized including, but not limited to, the type of 
altitude, NH versus HH, the type of exposure, rest as opposed to exercise, as well as the 
measurement techniques employed (Mackenzie et al., 2008).  
Plasma EPO concentration has been reported to reach its apex approximately 3-4 
d after initial exposure, upon which time it begins to slowly descend until steadying to 
proportions marginally exceeding those reported at SL (Rasmussen et al., 2013). 
Increases in EPO do not immediately result in the production of red blood cells (RBCs), 
or the process known as erythropoiesis (Ostadal & Kolar, 2007). As a result of the 
sizeable variations reported in EPO release, RBC production also displays high 
variability in response to altitude exposure. A recent systematic review of altitude-
induced RBC production suggested that for altitudes exceeding 4000 m, the minimum 
exposure time required to elicit significant RBC increases was 2 wk, indicating lengthy 
time lag between the increase of serum EPO levels and subsequent increase in RBC 
volume. Further, the authors proposed that if erythropoiesis is a primary objective, 
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utilizing altitude less 3000 m may be a fruitless endeavor as 4 wk exposures at this 
altitude did not significantly increase RBC volume. Finally, and in contrast to other 
acclimatization effects, the authors reported finding no evidence to suggest that 
significant differences exist in RBC production between investigations using HH or NH 
(Rasmussen et al., 2013).  
Other potential hematological mechanisms occurring during altitude exposure to 
combat the diminished ambient PO2 include an increase in both Hb and Hct 
concentrations, both of which lead to increases in the blood’s O2 carrying capacity 
(Ostadal & Kolar, 2007) . Though, both of these increases appear to be the result of a 
decreased plasma volume via renal diuresis, with significant changes typically not seen 
until after exposure times surpass multiple days in length (Wagner, 2000; Wyatt, 2014). 
Moreover, it appears more likely that Hb concentration (Hbcon), rather than Hb mass 
(Hbmass), is elevated during exposure to altitudes as low as 1500 m. This provides further 
evidence of the reduction in plasma volume occurring within 24-48 h of initial ascent. 
Indeed, at more severe altitudes in the range of 3000-4000 m, an increase in Hbcon rises 
approximately 0.5-1.0 g/mL of blood, corresponding to a reduction of 0.2-0.3 L plasma 
volume (P Bärtsch & Saltin, 2008; Calbet et al., 2004). However, while an increased 
Hbcon in and of itself would provide greater O2-carrying capacity, prior studies have 
reported that such changes would lead to elevated blood viscosity, which may negatively 
impact CO, thus potentially negating any benefit of a rise in hemoconcentration 
(Christopher John Gore et al., 2007; Naeije, 2010; Wagner, 2000).  Although there is 
evidence of a strong relationship between Hbmass and VO2max, the correlation between the 
two is weak and only capable of explaining 14% of the variance in VO2max (Saunders, 
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Garvican-Lewis, Schmidt, & Gore, 2013). Yet, even in the absence of a significant 
increase in Hbmass, there may still be a potential increase in the systematic transport of O2 
due to an increase in the enzyme 2,3- diphosphoglycerate (2,3-DPG). Hypoxic conditions 
lead to increased levels of circulating 2,3-DPG to lower O2’s affinity to Hb, which would 
serve to expedite the dissociation of O2 and Hb, thus increasing PAO2 and ultimately 
CaO2 (S. A. Gallagher & Hackett, 2004; Hahn & Gore, 2001). Further, the reduction to 
plasma volume, and thus, blood volume, has been reported to persist for 2-4 months after 
introduction to altitude (Calbet et al., 2004). A potential side effect, and one of particular 
concern for individuals during the initial days of altitude exposure is that the combination 
of the HVR, thus an increased amount of water vapor loss due to respiration, and renal 
diuresis may increase the risk of dehydration, primarily for those individuals training at 
altitude (Hahn & Gore, 2001; Wyatt, 2014). 
Additionally, a series of adjustments related to cardiovascular function are 
believed to occur during acute altitude introduction, namely the change in CO via an 
altered HR. It has previously been reported that within the first few hours upon 
introduction to high altitude settings, there occur significant elevations in resting HR 
(Eckardt et al., 1989; Kato et al., 2004); still, more current work points to the contrary 
(Ofner et al., 2014). As a result of the elevated HR, CO would be elevated, relative to 
normoxic conditions, in response to the decrements to PO2 and resultant drop in arterial 
O2 content (CaO2) (Wyatt, 2014). Conversely, there does appear to be some unanimity in 
the belief that CO actually decreases during high altitude conditions, although uniformity 
as to the effect of moderate altitudes on CO has yet to be attained (Pascal Mollard et al., 
2007; Wagner, 2000). However, recent reviews suggested that while moderate levels of 
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hypoxia do indeed precede the onset of tachycardia, and ensuing rise in CO, a response 
which appears to be sufficient to counter the drop in PO2 present in moderate hypoxia, 
both exercise and more austere hypoxic conditions prove too demanding for a similar, 
equitable increase in CO to offset the severity of hypoxemia (Naeije, 2010; Siebenmann 
& Lundby, 2015). However, despite the inconsistencies in results related to the hypoxic 
effect on both HR and CO, prior works do appear to agree that SV remains unaltered and 
that any change in CO that may or may not present under acute hypoxic stress is related 
to changes in HR (Pascal Mollard et al., 2007; Siebenmann & Lundby, 2015; Wagner, 
2000).  
As altitude contact time increases, either through continued stays or repeated, 
intermittent exposures, cardiovascular adaptations carry on to bring about further 
acclimatization. With an exposure time surpassing 2-3 d, the majority of research 
suggests CO returns to near baseline levels (Farinelli, Kayser, Binzoni, Cerretelli, & 
Girardier, 1994; Hainsworth & Drinkhill, 2007; Naeije, 2010). Yet, other studies have 
reported findings conflicting with this theory (Ostadal & Kolar, 2007). However, while 
HR may decline in comparison to HR values upon initial introduction to altitude; HR, 
both at rest and during submaximal exercise, remains somewhat elevated compared to SL 
values. Further, both COmax and HRmax at altitude has been shown to be significantly 
lower when compared to SL control values, even in acclimatized individuals (Farinelli et 
al., 1994; Favret, Henderson, Richalet, & Gonzalez, 2003; Naeije, 2010; Wagner, 2000). 
One potential explanation for the alterations in HR upon altitude exposure may be related 
to enhanced sympathetic nervous system activity with acute exposure and 
parasympathetic activity increases during the acclimatization process, possibly and 
29 
 
partially explaining the initial rise and eventual fall in resting HR values (Farinelli et al., 
1994; Naeije, 2010; Wagner, 2000). Further evidence for this theory was presented 
during the comparison of gradual and rapid ascents to altitude, whereas gradual ascents 
over 2 wk resulted in a 25% increase in resting HR, but a rapid ascent to the same altitude 
resulted in only a 9% increase in resting HR (Hainsworth & Drinkhill, 2007).  
The likely mechanism behind CO returning to near SL values while HR remains 
elevated is a decrease in SV. While SV begins to decline during acute altitude exposure, 
as exposure time increases and the acclimatization process unfolds, PV decreases as a 
result of diuresis, which leads to the drop in SV. This decline in SV occurs during 
approximately the initial 7 d of exposure, and begins to steady during sojourns extending 
beyond such lengths. The decline in plasma volume is dependent upon the severity of the 
hypoxic exposure with greater levels of hypoxia resulting in more significant declines in 
PV (Peter Bärtsch & Gibbs, 2007; Hainsworth & Drinkhill, 2007; Naeije, 2010; Wagner, 
2000). Further, there is evidence to suggest the aforementioned cardiovascular 
adaptations do remain relatively consistent with longer acclimatization periods as it has 
previously been reported that individuals remaining at elevation for significant periods of 
time as well as high-altitude natives have similar resting CO compared to SL controls 
while the long-term visitors and residents of high-altitude locations were also shown to 
display higher HR and lower SV than their lowland counterparts (Naeije, 2010). Finally, 
while there is some evidence that both NH and HH induce similar cardiovascular 
adaptations during altitude acclimatization, as the review by Ostadol & Kolar (2007) 
suggest, the plethora of methodologies utilized and presence of inter-individual variations 
have led to a lack of consensus on the matter. 
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In response to aerobic exercise during acute hypoxic conditions, similar patterns 
of inconsistency for HR have emerged. Previous investigations have reported significant 
increases in HR during both sub-maximal and maximal aerobic testing (Engelen et al., 
1996; Wagner, 2000); however, more recent works have reported either no differences or 
decreases in HR during sub-maximal and maximal efforts (Beidleman et al., 2014; C. A. 
Gallagher, Willems, Lewis, & Myers, 2014; Lundby, Araoz, & Van Hall, 2001; Pascal 
Mollard et al., 2007; Ofner et al., 2014).  
Similar to other physiological responses to exercise during acute altitude, some of 
the differences in HR alterations may be related to the training status of the participants 
in the aforementioned studies. One potential explanation for the varied responses between 
trained and untrained individuals may be related to SaO2 levels. The occurrence of 
exercise induced arterial hypoxemia (EIH), which presents in approximately 40-50% of 
highly-trained individuals (RVO2max > 60 mL ∙ kg
-1 ∙ min-1) (Chapman, Emery, & Stager, 
1999) during endurance exercise is a potentially determining factor of aerobic exercise 
performance during acute altitude exposure (Chapman et al., 1999; Christopher J Gore et 
al., 1996; Rusko et al., 2004; Terrados, Mizuno, & Andersen, 1985). This desaturation, 
defined as an SaO2 less than 92%, tends to be accentuated by an abrupt drop in ambient 
PO2, furthering the decrement to pulmonary gas exchange and consequently, reducing the 
availability of O2 for the working musculature (Amann & Calbet, 2008; Calbet et al., 
2003a; Chapman et al., 1999; Pascal Mollard et al., 2007). However, even if highly 
trained individuals do not display SaO2 levels below the EIH threshold, prior evidence 
has suggested that trained individuals still display significantly lower SaO2 levels than 
their untrained counterparts (Benoit, Busso, Castells, Geyssant, & Denis, 2003). Prior 
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investigations have reported that the body is capable of tolerating PaO2 levels in the range 
of 75-80 mm Hg with minimal falls in SaO2, however, any drop in PaO2 below that 
minimal threshold of approximately 75 mm Hg will tend to have a more substantial 
impact on SaO2 and thus negatively affect maximal exercise capacity (Bebout et al., 
1989; Chapman et al., 1999). Intriguingly, and in contrast to the varied effects between 
HH and NH on HVR, HR may not exhibit different responses between the two forms of 
hypoxia as Beidleman and colleagues (2014) reported no differences in HR response 
between NH and HH for fit males performing cycling exercise intensities of 45% and 
65% of their VO2max at a simulated altitude equivalent to 4300 m. In support of the 
aforementioned findings, a recent systematic review of crossover trials revealed 
ambiguous HR results between HH and NH conditions (Coppel, Hennis, Gilbert-Kawai, 
& Grocott, 2015). 
Despite the lack of clear evidence as to which physiological systems, and to what 
extent they influence the human body’s ability to respond to a sudden decline in PiO2, 
there does appear to be consistency in the evidence that maximal aerobic capacity is 
significantly diminished upon acute exposure to altitude. While there is some evidence 
that the decline in aerobic capacity may be observed with ascents to low altitudes of 
approximately 600-700 m (Chapman et al., 1999; Hahn & Gore, 2001; Wyatt, 2014), a 
more accepted theory is that significant detriments to VO2max, and thus aerobic endurance 
performance, occur in a linear manner beginning at an altitude, or its synthetic equivalent, 
of 1500 m (Peter Bärtsch & Gibbs, 2007; M Burtscher et al., 2006; Chapman et al., 1999; 
Muza, 2007; Ofner et al., 2014). Further, a pattern of considerable interest to the current 
investigation has emerged in that trained individuals are prone to a more significant 
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decline in VO2max during acute exposure than their untrained counterparts (Raphael Faiss, 
von Orelli, Deriaz, & Millet, 2014; Lawler, Powers, & Thompson, 1988; Mollard et al., 
2008; P Mollard et al., 2007). As Calbet et al. (2002) so succinctly described, the 
detrimental consequence of hypoxia related to maximal aerobic capacity appears to be the 
result of a decline in ambient PO2 and ensuing reduction in the PiO2, diminishment of 
pulmonary gas exchange, and degradation of COmax, which, combined, account for the 
deterioration of VO2max. 
Submaximal and maximal aerobic exercise performance continue to recover from 
initial decrements suffered during early exposure periods as improvements to both the 
former and the latter are brought about via crucial adaptations in pulmonary ventilation, 
hemoconcentration, and cardiovascular function, as well as other exercise related 
adaptations associated with continued or repeated exposures to altitude (Beidleman et al., 
2004; Fulco et al., 2013; N. Garcia, S. R. Hopkins, & F. L. Powell, 2000; Muza, 2007; 
Muza et al., 2010; Ostadal & Kolar, 2007; Saunders et al., 2013; Saunders et al., 2004; 
Schommer et al., 2012). These longer-term adaptations related to endurance exercise 
performance will be the focus of the next segment of this review of literature as the 
efficacy of the multitude of both past and present altitude training strategies will be 
examined. 
Altitude Training Strategies 
 The traditional method employed for altitude training involves both living and 
training at high altitude settings (1500-3000m), or Live high-Train high (LHTH). This 
classical model first emerged nearly six decades ago (Christopher John Gore et al., 2007; 
Gregoire P Millet et al., 2010) and is still frequently utilized by endurance athletes and 
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mountaineers, both by SL dwelling athletes and permanent residents of moderate to high 
altitude locations (Hahn & Gore, 2001; Michael J Hamlin et al., 2013; Wilber, 2007a; 
Wolfarth, 2005). Despite equivocal results to date concerning the efficacy of LHTH, this 
model has been utilized both to provide altitude acclimatization and to provide an 
additional training stimulus, the former being crucial for performance at altitude and the 
latter for performance at or near SL (Friedmann‐Bette, 2008; Christopher John Gore et 
al., 2007; Igor, Vladimir, Milos, & Goran, 2011; Wilber, 2001, 2007a; Wolfarth, 2005).  
 For SL athletes travelling to moderate to high altitude locations for exercise 
training purposes, these training camps are typically scheduled 2-3 times per year, with 
each trip lasting approximately 2-4 wk (Hahn & Gore, 2001; Gregoire P Millet et al., 
2010). Due to the complexity of altitude acclimatization (P Bärtsch & Saltin, 2008; M 
Burtscher et al., 2008; Fulco et al., 2013; S. A. Gallagher & Hackett, 2004; Muza et al., 
2010) and the inter-individual variation of acclimatization (Chapman, 2013; Chapman et 
al., 1998; Tannheimer et al., 2009), LHTH camps typically adhere to similar schedules in 
an attempt to provide the most effective training stimulus for the athletes. These 
schedules include an acclimatization phase (7-10 d), the primary training phase (2-3 wk), 
and the recovery phase (2-5 d).  For athletes returning to near SL for competition, an 
additional phase is necessary to allow the athletes to re-acclimate. The ideal duration of 
this phase is currently under debate, with the various strategies ranging from 2-21 d 
following the departure from the altitude training site (Bonetti & Hopkins, 2009; 
Chapman, Stickford, Lundby, & Levine, 2014; Gregoire P Millet et al., 2010). However, 
despite continued residence at altitude being the most effective strategy to induce 
acclimatization, the LHTH method does present certain aspects which may counteract the 
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primary purpose for such training endeavors (Gregoire P Millet et al., 2010; Wilber, 
2007a).  
 A notable concern for the implementation of LHTH is the detriment to training 
intensity due to elevation (Christopher John Gore et al., 2007; B. Levine & Stray-
Gundersen, 1992; Gregoire P Millet et al., 2010; Rusko et al., 2004; Wilber, 2007a). This 
issue has been reported both anecdotally and scientifically as elite athletes returning from 
LHTH camps displayed diminished training intensities at altitude as well as performance 
decreases of 3-8% upon return to SL, supporting the idea that the potential training 
benefit of hypoxia is outweighed by the decline in training intensity (B. D. Levine & 
Stray-Gundersen, 1997; Wilber, 2007a). This decline in training intensity may be brought 
about via a combination of mechanisms related to exercise under hypoxic conditions. The 
previously described EIH known to effect elite endurance athletes may substantially 
decrease submaximal training intensities and speeds (Christopher J Gore et al., 1996; 
Hahn & Gore, 2001; B. D. Levine & Stray-Gundersen, 1997; Rusko et al., 2004). Further, 
the alterations in HR and CO that present under hypoxic conditions, both to submaximal 
and maximal values, is likely to impact training at altitude (Rusko et al., 2004). 
Additionally, body mass (BM) losses may occur during prolonged stays at altitude, 
especially when physical activity levels are high, as is the case with endurance athletes 
and mountaineers. It has previously been reported that BM losses of up to 4% may occur, 
with two-thirds of said loss resulting from declines in lean BM, with the authors noting 
that similar values have been reported in similar studies (Zaccagni, Barbieri, Cogo, & 
Gualdi-Russo, 2014).  Moreover, recovery may be negatively impacted as sleep quality is 
inhibited during LHTH camps. These sleep disruptions in the form of disordered 
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breathing and arousals may last up to two weeks upon arrival to altitude (Christopher 
John Gore et al., 2007; Sargent et al., 2013). Further, multiple reviews examining the 
efficacy of altitude training strategies have cited numerous works reporting impairments 
to immune function in athletes traveling to and training at altitude (Friedmann‐Bette, 
2008; Christopher John Gore et al., 2007; Rusko et al., 2004). 
 One of the original purposes for supplementing altitude training into normal 
endurance training programs was/is the credence that hypoxic exposure will lead to 
increases in RBC volume, theoretically leading to improvements in VO2max and 
consequently an improved race performance (Friedmann‐Bette, 2008; Hahn & Gore, 
2001; Gregoire P Millet et al., 2010; Wilber, 2007a; Wolfarth, 2005). Based on the 
aforementioned time schedules and altitude severity adhered to during the majority of 
LHTH camps, the evidence as to whether such endeavors are efficacious at improving the 
variables related to endurance performance of elite athletes has been equivocal to date. 
The meta-analysis conducted by Rasmussen et al. (2013) suggested that an exposure 
duration greater than 2 wk at an elevation of 4000 m is necessary to induce significant 
RBC volume increases while also proposing that for altitudes less than 3000 m, 4 wk 
sojourns may not lead to substantial increases in RBC volume. However, prior works 
have reported significant increases in RBC volume both in elite biathletes after only a 3 
wk stay at only 2050 m (Wolfarth, 2005) and while an earlier investigation reported 
significant increases in RBC volume of elite runners after a 4 wk residence at an altitude 
of 2500 m (B. D. Levine & Stray-Gundersen, 1997). However, there does appear to be 
consensus concerning an individual’s training status and the length of stay at altitude 
necessary to elicit significant increases in RBC volume as multiple works have suggested 
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that highly-trained individuals may require longer stays as they are closer to their 
physiological ceiling and thus require greater amounts of stimulation to elicit the desired 
hematological adaptations (Rasmussen et al., 2013; Wolfarth, 2005). 
 As previously mentioned, altitude acclimatization processes require 
approximately 1-3 wk (Fulco et al., 2013; Fulco et al., 1998; Muza, 2007; Muza et al., 
2010); however, endurance training performances may necessitate even longer exposure 
durations before standard training intensities may be resumed and the full benefit of the 
hypoxic training stimulus can be exploited (Calbet et al., 2003b; Fulco et al., 2013; Hahn 
& Gore, 2001). To this point, prior works have shown that 2-3 wk of altitude exposure 
have led to 20-60% increases of submaximal endurance performance at altitude 
compared to initial exposure. Yet, there is little to no evidence that similar exposure 
durations bring about enhancements of VO2max in hypoxic settings (Beidleman et al., 
2007). Further, there is evidence to suggest that even with a proper acclimatization period 
VO2max remains compromised due to factors other than O2 delivery to working 
musculature (Calbet et al., 2003b; Hahn & Gore, 2001). In an attempt to expedite the 
acclimatization process, there are medications available to reduce one’s risk and/or 
symptoms of AMS and other high-altitude illnesses; but, these medications present a 
number of adverse side effects as well as aggravate the reduced exercise tolerance at 
altitude, limiting their usefulness for athletes (Fulco et al., 2013).  
 As multiple reviews of altitude training strategies have noted, continued residence 
at altitude, as is utilized during LHTH, is regarded as a  decidedly effective 
acclimatization practice, yet other factors such as detriments to both health and aerobic 
exercise capacity have proved disadvantageous in attempts to enhance endurance 
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performance, specifically at SL (Hahn & Gore, 2001; Gregoire P Millet et al., 2010; 
Wilber, 2007a). Further, resources such as time and money have also impacted the 
implementation of LHTH camps.  Collectively, these factors guided efforts to develop 
other altitude training methods (B. D. Levine, 2002; Wilber, 2001). 
 As a result of the aforementioned complications resulting from the classical 
LHTH altitude training model, a more contemporary approach was introduced in the 
early 1990s. This newer altitude training strategy of Live high-Train low (LHTL), which 
employed the potential benefits of altitude acclimatization, or living high, and endurance 
training without compromising intensity, or training low, was developed jointly by Dr. 
Benjamin Levine and Dr. Stray-Gundersen (Christopher John Gore et al., 2007; Gregoire 
P Millet et al., 2010; Wilber, 2007a). However, many athletes faced geographical 
limitations and were unable to carry out LHTL camps without significant costs, financial 
and otherwise (Christopher John Gore et al., 2007). Such restrictions eventually led to 
technological advancements that have born multiple methods to fulfill the LHTL strategy 
are now available. There are multiple comprehensive reviews detailing the various 
strategies currently employed (Bonetti & Hopkins, 2009; Gregoire P Millet et al., 2010; 
Wilber, 2001, 2007a) but for this review, LHTL will be used to refer to all possible 
methods; however, where applicable to the present investigation, distinctions between 
studies utilizing HH and NH will be presented.  
 Despite the abundance of studies investigating the efficacy of LHTL to improve 
SL performance (Bonetti & Hopkins, 2009; Chapman, Stickford, et al., 2014; Raphaël 
Faiss, Girard, & Millet, 2013; Fulco, Rock, & Cymerman, 2000; Christopher John Gore 
et al., 2007; Hahn & Gore, 2001; Humberstone-Gough et al., 2013; Gregoire P Millet et 
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al., 2010; Wilber, 2001; Wilber, Stray-Gundersen, & Levine, 2007),  there remains a 
paucity of research efforts regarding the benefits or detriments of LHTL related to 
endurance performance in hypoxic conditions (Fulco et al., 2013; Hahn & Gore, 2001; 
Siebenmann et al., 2012). Further, empirical evidence regarding the ability of LHTL 
protocols to reduce either the prevalence or severity of high-altitude illnesses is extremely 
limited. Individuals participating in LHTL protocols are at greater risk of developing 
symptoms of AMS rather than HACE or HAPE, which are typically not a concern as 
LHTL protocols are conducted at altitudes or their simulated equivalents below the 
threshold for the development of either the former or the latter (Schommer et al., 2012). 
The initial symptoms of AMS typically occur within the first hours of exposure to an 
altitude exceeding 2400 m (S. A. Gallagher & Hackett, 2004; Muza et al., 2010; Richard 
et al., 2014).  Yet, according to multiple review articles pertaining to LHTL (Bonetti & 
Hopkins, 2009; Hahn & Gore, 2001; Gregoire P Millet et al., 2010), as well as more 
recent original work (Chapman, Karlsen, et al., 2014),  the recommended maximum 
altitude severity for such endeavors is equivalent to approximately 2500 m, which may 
attenuate any concerns regarding AMS.  
 While the current literature may be slight regarding the efficacy of LHTL 
protocols to elicit HVR adaptations (Hahn & Gore, 2001; Wilber, 2007a), current LHTL 
recommendations do appear to be sufficient to provoke such responses. The initiation of 
the HVR is brought about via the hyperventilation that commences nearly 
instantaneously upon introduction to altitude (Hahn & Gore, 2001; Townsend et al., 
2002). Utilizing NH during an LHTL investigation, researchers have shown that resting 
blood pH is significantly increased after 10 d of 16 h per day of exposure, indicating the 
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presence of respiratory alkalosis, which is often the result of increased VE (Nummela & 
Rusko, 2000). Further, a prior study has also reported that LHTL protocols with total 
exposure time of at least 88 h (11 d x 8 h per night) is sufficient to significantly reduce 
the partial pressure of CO2 (PCO2). Additionally, the same research team reported 
significant increases in SpO2 of elite athletes after only 4 d of sleeping 8-11 h per night in 
NH equivalent to altitude ranges of approximately 2650-3000 m (Hahn & Gore, 2001). 
However, others have reported no change in resting VE upon completion of a 20 d LHTL 
protocol using NH equivalent to 2650 m in which the researchers utilized two LHTL 
protocols, one in which participants slept 8-11 h per night for 20 d consecutively at the 
aforementioned simulated altitude, referred to as the continuous group, and another 
LHTL group, which performed four cycles of sleeping 5 d in NH followed by 2 d in 
normoxia, referred to as the intermittent group. These authors did report significantly 
lower resting end-tidal pressure of CO2 (PetCO2) levels compared to the control group in 
both the continuous and the intermittent groups. Intriguingly, they also reported a 
significant decline in PetCO2 from the initial measure to the measurement taken after 15 
d of sleeping in NH in the intermittent group, as well as a lower, but not significant, 
PetCO2 observed in the continuous group. Based on these findings, the authors proposed 
that the HVR response was more distinct in the continuous group as compared to the 
intermittent LHTL group (Townsend et al., 2002). Additional studies have also reported 
significantly differences in VE during submaximal but not maximal running in highly 
trained runners. During a terrestrial altitude LHTL investigation the responses of trained 
runners living at four different locations with altitudes of 1780, 2085, 2454, and 2800 m, 
respectively. The authors reported that while there was no difference in maximal VE 
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following the 4 wk protocol, submaximal VE was significantly decreased in the group 
living at 1780 m, while VE displayed lower, albeit nonsignificant, for the 2085 m group. 
Further, submaximal VE was significantly greater in the 2454 m group as well as 
elevated, but not significantly, in the 2800 m group. Additionally, after a 2 wk 
deacclimatization period, submaximal VE was still significantly depressed for the athletes 
who resided at 1780 m, while the athletes living at the two highest altitudes still exhibited 
greater, but not significant, VE levels during submaximal exercise (Chapman, Karlsen, et 
al., 2014).   
 In addition to shorter-term ventilatory responses, there is also evidence of genetic 
HVR adaptations. When comparing the two high-altitude native populations of the Andes 
and Tibet, it has been reported that the former has adapted to the altitude via 
hematological changes while the former have adapted via a resting VE 1.5 times that of 
their Bolivian counterparts. Further, it has also been reported that the Tibetan natives 
have an HVR that is twice that of the Andean residents. Such responses have led some 
researchers to conclude that individuals such as Tibetan Sherpas are more capable than 
most during high-altitude expeditions due to the elevated HVR, correlating to more 
efficient O2 delivery (Christopher John Gore et al., 2007). Interestingly, and of particular 
consequence for practitioners of LHTL, the HVR may be a key beneficial adaptation for 
strenuous activity in mountainous regions, but it may also be detrimental to athletes 
competing at or near SL. Based on the findings from their LHTL investigation utilizing 
four separate natural altitude locations, Chapman, Karlsen, et al. (2014) proposed that an 
enhanced HVR brought about during altitude acclimatization may have a potentially 
negative impact on endurance performance at or near SL via the increased energy and O2 
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costs of breathing. This proposal may be supported via prior work reporting that 
endurance trained athletes display lower HVRs than untrained, but otherwise healthy 
individuals (Townsend et al., 2002). 
 In contrast to the dearth of empirical evidence related to ventilatory 
acclimatization, the current literature is replete with data related to hematological 
adaptations resulting from LHTL. Nevertheless, the sheer quantity of available evidence 
regarding EPO, Hct, Hb, and RBC changes has failed to produce consistently positive 
results, possibly related to the multitude of methodological differences, which only serves 
to fuel the controversy surrounding the efficacy of LHTL (Bonetti & Hopkins, 2009; 
Christopher John Gore et al., 2007; Wilber, 2001, 2007a).  
 One of the more popular justifications for implementing LHTL, or any form of 
altitude training for that matter, is the theoretical increase in EPO and thus, the eventual 
enhancement of the O2-carrying capacity of the blood (Brocherie et al., 2015; Gregoire P 
Millet et al., 2010; Wilber, 2001, 2007a). In contrast to the other hematological variables 
to be discussed, there does appear to be consensus regarding the effects of hypoxic 
exposure on the increased production of EPO as it is well established that after 
approximately 2 h of introduction to hypoxic conditions, EPO concentration begins to 
rise and reaches peak levels after 3-4 d of exposure, after which it generally settles to 
levels slightly elevated compared to baseline measures (Ashenden et al., 2000; S. A. 
Gallagher & Hackett, 2004; Christopher John Gore et al., 2007; Rasmussen et al., 2013). 
Further, multiple LHTL studies and comprehensive reviews have reported EPO 
concentration increases employing both HH (Chapman, Karlsen, et al., 2014; Hahn & 
Gore, 2001) and NH (Ashenden et al., 2000; Siebenmann et al., 2012; Wilber, 2007a) 
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protocols following the aforementioned time paradigm for EPO levels relative to hypoxic 
exposure. 
 Following the rationale of the predominant model for the hematological 
adaptations resulting from exposure to hypoxic conditions, the production and subsequent 
increased EPO levels initiate the generation of RBCs in bone marrow (Clark et al., 2009; 
Saunders et al., 2013). However, while the pathway is a well-accepted theory, whether or 
not the hypoxic stimulus brought about via altitude training practices such as LHTL 
models is sufficient to yield such a response remains widely debated (Clark et al., 2009; 
Rasmussen et al., 2013; Robach et al., 2012; Saunders et al., 2013; Schmidt & Prommer, 
2010). Additionally, the distinction between Hbmass and Hbcon has become increasingly 
relevant as changes in Hbmass would indicate changes in RBC volume whereas changes in 
Hbcon are likely to only be an indication of a change in total blood volume, with the 
former being the true adaptation researchers and endurance coaches are interested in with 
respect to its implications on VO2max and the latter signaling acclimatization without 
necessarily impacting aerobic capacity (Hahn & Gore, 2001; Rasmussen et al., 2013; 
Saunders et al., 2013; Wilber, 2007a). 
 In addition to EPO, Hb and the concomitant RBC volume are also of particular 
interest during LHTL investigations due to their role in systematic O2 transport 
(Brocherie et al., 2015; Humberstone-Gough et al., 2013; Siebenmann et al., 2012). 
However, the disparity regarding the effects of elevated EPO levels after hypoxic 
exposures centers on whether or not said increases lead to increases in Hbmass (Robach et 
al., 2012; Saunders et al., 2013; Schmidt & Prommer, 2010; Siebenmann et al., 2012) and 
RBC volume (Chapman, Karlsen, et al., 2014; Rasmussen et al., 2013). Inquiries of the 
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standard LHTL model, which were conducted in geographically feasible locations in 
order for participants to both live and train in naturally high and low altitudes, 
respectively, have previously produced positive results for both Hbcon and Hbmass 
compared to their fitness-matched control groups. Participants, who were sub- and elite-
level athletes for their respective sports, completed 24-28 d LHTL protocols while living 
at 2500 m and training at altitudes ranging from 1000-1800 m (Wilber, 2007a).  
 Prior studies investigating the effects of LHTL via NH on highly-trained athletes 
failed to demonstrate significant changes in Hbcon and reticulocyte levels (Ashenden et 
al., 2000)  or Hbmass (Ashenden, Gore, Martin, Dobson, & Hahn, 1999; Robach et al., 
2012; Saunders et al., 2004; Siebenmann et al., 2012). Adding to the lack of clarity on the 
matter, multiple studies reporting no changes in Hbmass also reported significant 
escalations of reticulocyte counts (Aulin, Svedenhag, Wide, Berglund, & Saltin, 1998; 
Robach et al., 2012; Siebenmann et al., 2012). Each of the aforementioned studies 
included a control group and followed the generally accepted LHTL guidelines for both 
altitude severity and total exposure time. The importance of conducting LHTL studies 
with a control group when evaluating the effects on blood parameters has previously been 
addressed due to the potential of endurance training to increase said variables (Ashenden 
et al., 2000). Contrasting with the above-mentioned works, others have described 
substantial increases in Hbmass after completion of NH-based LHTL procedures. Multiple 
placebo-controlled inquiries reported significant increases in Hbmass following their 
respective LHTL protocols (Brocherie et al., 2015; Brugniaux, Schmitt, Robach, Nicolet, 
et al., 2006; Humberstone-Gough et al., 2013). Yet, Brugniaux et al. (2006) performed 
follow-up testing after a 15 d deacclimatization period and indicated that Hbmass had 
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returned to baseline levels. 
 Similar inconsistencies as to the effectiveness of LHTL methods to significantly 
improve both VO2max and endurance performance measures have been reported. 
However, as the majority of the current literature has focused on augmenting the 
performance of sub- and elite-level athletes from long-distance running to orienteering, 
even minute improvements may be of consequence (Brocherie et al., 2015; Raphaël Faiss 
et al., 2013; Fulco et al., 2000; Christopher John Gore et al., 2007; Gregoire P Millet et 
al., 2010; Wilber, 2001).  To demonstrate, while the empirical evidence concerning the 
efficacy of LHTL to improve SL performance remains somewhat inconclusive due to 
statistical insignificance, anecdotal support remains steadfast as a result of more applied 
findings (Bonetti & Hopkins, 2009; Chapman, Karlsen, et al., 2014; Chapman, Stickford, 
et al., 2014; Raphaël Faiss et al., 2013; Fulco et al., 2000; Hahn & Gore, 2001; McLean, 
Gore, & Kemp, 2014; Wilber, 2007a). Further, as a primary objective of LHTL practices 
is to improve endurance performance at or near SL, minimal attention has been given to 
the efficacy of LHTL to enhance aerobic performance at moderate to high altitudes. To 
this point, authors of a comprehensive review conducted 10 yr after the initial 
introduction of LHTL failed to identify a single study examining the effects of LHTL on 
VO2max or endurance performance in a hypoxic setting (Hahn & Gore, 2001). Further, for 
the studies that have examined aerobic endurance performance in hypoxic conditions 
following an LHTL protocol, inconclusive results have been reported as a 3 wk LHTL 
investigation employing terrestrial altitude described an 8.9% improvement in VO2max at 
2340m, albeit without the benefit of a control group (Schuler, Thomsen, Gassmann, & 
Lundby, 2007). However, an NH-based LHTL methodology failed to elicit any aerobic 
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capacity improvements (Siebenmann et al., 2012), which appears to support earlier 
research that despite the enlargement in other indicators of acclimatization such as Hb 
and SaO2, VO2max remains compromised (Bebout et al., 1989; Calbet et al., 2003b). 
Based on the empirical evidence currently available, while current LHTL practices 
utilizing living altitudes ranging from 2000-3000 m for 2-4 wk may be sufficient to elicit 
some facets of altitude acclimatization, whether or not this particular form of altitude 
training is adequate to dramatically improve performance at moderate to high altitudes 
remains to be seen (Calbet et al., 2003a; Calbet et al., 2003b; Fulco et al., 2011; 
Siebenmann et al., 2012). 
 While the advancement of altitude training technologies all but eliminated the 
geographical and reduced the financial limitations, respectively, of the LHTL strategy, 
certain obstructions remained for some individuals wishing to carry-out this particular 
form of altitude training. The conversion of residences into nitrogen houses or sleeping in 
hypoxic tents potentially remained too burdensome, and time-consuming, for some 
athletes (Michael John Hamlin & Hellemans, 2007). In an effort to expedite the 
acclimatization process, and theoretically enhance athletic performance, a subset of 
LHTL emerged and discontinuous exposure to hypoxic conditions, or IHE, was 
established (B. D. Levine, 2002; Mekjavic, Debevec, Amon, Keramidas, & Kounalakis, 
2012; Muza, 2007; Powell & Garcia, 2000). Further, since LHTL involving natural 
altitude requires the individuals to relocate to mountainous regions, this aspect diminishes 
the military’s capabilities for the rapid deployment of personnel (Muza, 2007). Though 
IHE may be a seemingly recent development related to athletic performance (B. D. 
Levine, 2002), its potential to induce altitude acclimatization (Stickney & Van Liere, 
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1953) as well as its effectiveness and logistical necessity to prepare mountaineers for 
ascents of peaks exceeding 8000 m (Powell & Garcia, 2000) have been investigated and 
practiced, respectively, for many years. Indeed, the mountaineering procedure of 
ascending and then returning to a base camp established at a lower elevation to sleep, eat, 
and collect more supplies stemmed from pure necessity but led to inadvertently greater 
altitude acclimatization via shorter-term exposures while climbing to higher elevations 
followed by recovery periods at base camp (Powell & Garcia, 2000).  
 Altitude acclimatization appears likely to correspond to the dosage of altitude 
exposure, which is a product of the  total exposure duration (the duration of each IHE 
session x the total number of IHE sessions) and the  severity of hypoxia. If IHE is to elicit 
a similar level of acclimatization as LHTL, then the severity of altitude must be increased 
as a result of the decreased total exposure times. For the purposes of this review, IHE will 
refer to protocols utilizing ≤ 8 h ∙ d-1 of hypoxic exposure during resting conditions as the 
majority of LHTL protocols employed daily exposure durations typically exceeding 8 h ∙ 
d
-1
 (Bonetti & Hopkins, 2009; Brugniaux, Schmitt, Robach, Jeanvoine, et al., 2006; 
Nathalie Garcia et al., 2000; Gregoire P Millet et al., 2010; Muza, 2007; Wilber, 2001, 
2007a). In a comprehensive review of hypoxic training strategies, Muza (2007) elucidates 
this inverse relationship between IHE duration and  hypoxia severity. One potential 
justification for the selection of either LHTL of IHE may be related to the overall benefits 
desired. If the desired outcome is to improve athletic performance at or near SL, then 
hematological outcomes are of primary interest and longer exposure durations such as 
those utilized during LHTL protocols are typically selected. If ventilatory adaptations 
related to acclimatization for a future ascent to terrestrial altitude are of primary interest, 
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then IHE may be sufficient to reduce the risk of AMS (Beidleman et al., 2004; M 
Burtscher et al., 2008; Fulco et al., 2013) and possibly augment exercise in hypoxic 
conditions (Faulhaber, Dünnwald, Gatterer, Bernardi, & Burtscher, 2012; Katayama et 
al., 2001). 
 The current literature regarding the efficacy of IHE, as defined above, protocols to 
reduce the risk of AMS appear to be limited, but promising. A pivotal study on the 
subject revealed that 60 h of HH exposure time (15 d of 4 h ∙ d-1 exposure duration) was 
sufficient to both reduce the risk and severity of AMS during a 30 h exposure to HH 
equivalent to 4300 m (Beidleman et al., 2004). While prior works have suggested that 
acute exposure to HH induces a greater physiological strain than NH, and thus HH would 
be more effective at reducing the risk of AMS upon exposure to terrestrial altitude 
(Loeppky et al., 1997; R. C. Roach et al., 1996) others have reported contrasting results 
(Richard et al., 2014). To further illustrate, an NH-based LHTL procedure consisting of 
only 5 nightly exposures during sleep at an altitude equivalent of 4300 m significantly 
decreased the occurrence of AMS after the initial two exposures (Kolb, Ainslie, Ide, & 
Poulin, 2004). 
 Multiple studies using HH-based IHE protocols have demonstrated their 
respective usefulness to induce ventilatory adaptations consistent with acclimatization 
including a rise in resting HVR in hypoxic conditions (Beidleman et al., 2004; Faulhaber 
et al., 2012; Fulco et al., 2013; Katayama, Sato, Ishida, Mori, & Miyamura, 1998; 
Katayama et al., 2001), as well as other implications of acclimatization including, but not 
limited to, an increased resting (Beidleman et al., 2004; Katayama et al., 1998; Rodríguez 
et al., 2000) and exercise (Beidleman et al., 2007; Chapman et al., 1998; Katayama et al., 
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2001; Ricart et al., 2000) SaO2 levels. Yet other works have detailed no significant 
changes to variables associated with altitude acclimatization. A 4 wk HH-based IHE 
protocol of 3 h ∙ d-1 of 5 d ∙ wk-1 did not increase submaximal (Truijens et al., 2008) or 
maximal (Rodriguez et al., 2007) VE in trained runners and swimmers.  
 The efficacy of NH-based IHE studies remains somewhat unclear as only limited 
evidence is currently available supporting the use of NH-IHE protocols of less than 8 h∙d-
1
 exposure duration to elicit acclimatization and/or hypoxic performance enhancements 
(Michael John Hamlin & Hellemans, 2007; Mekjavic et al., 2012; Muza, 2007).  
Although sparse, and contrary to the majority of prior works reporting significant 
differences of the physiological responses observed between HH and NH conditions 
(Raphael Faiss et al., 2013; Loeppky et al., 1997; R. C. Roach et al., 1996; Savourey et 
al., 2003; Tucker, Reeves, Robertshaw, & Grover, 1983) there is some evidence that the 
timeline for the HVR response during NH-based IHE sessions does appear to follow the 
time elapse pattern of HVR during exposure to terrestrial altitude, with the NH-induced 
HVR stabilizing within a few days of the initial exposure (Sheel & MacNutt, 2003). 
Previous work has demonstrated a significant increase in individual HVR as early as 5 d 
after the initial IHE session, yet also reported no changes in group mean HVR from 
baseline after an additional 7 d, 12 d total, of IHE using an NH equivalent of 3800 m (N. 
Garcia, S. Hopkins, & F. Powell, 2000). A more recent inquiry reported that only four 
IHE sessions over a 4 d period using the NH equivalent of 4200 m induced significant 
improvements of 15% and 4% for VE and SpO2, respectively, during a constant power 
test (Debevec & Mekjavic, 2012). Further complicating the matter is the interaction of 
the physiological systems involved in acclimatization, as the potentially beneficial 
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ventilatory alterations may be at least partially undone via metabolic adjustments during 
submaximal exercise in hypoxic settings (M Burtscher, Gatterer, Faulhaber, Gerstgrasser, 
& Schenk, 2010). Additionally, neither submaximal cycling exercise VE nor SaO2 levels 
were improved after a 7 d protocol at NH equivalent of 4500 m for individuals at NH 
equivalents to 2000, 3000, or 4000 m (Faulhaber et al., 2012).  
 IHE-induced hematological adaptations have not been as pronounced as the 
ventilatory adaptations and while not conclusive, current evidence tends to indicate that 
IHE protocols do not provide a sufficient stimulus to induce erythropoiesis (Debevec & 
Mekjavic, 2012; Christopher J Gore et al., 2006; B. D. Levine, 2002; Muza, 2007; Powell 
& Garcia, 2000) due to the time course of increased erythropoietin  levels resulting from 
a hypoxic stimulus (Eckardt et al., 1989). However, prior works have reported results 
somewhat to the contrary using IHE sessions of ≤ 2 h per exposure to elicit increased 
hemoconcentration via HH (Rodríguez et al., 2000) and increases to both 
hemoconcentration (M Burtscher et al., 2010) and reticulocyte count (N Garcia et al., 
2000) via NH-based IHE protocols.  
 IHE-induced enhancements of endurance performances during hypoxia is another 
topic of which the current literature is sparse. Katayama et al. (2001) reported no change 
in VO2max in a hypobaric chamber setting equivalent to 4500 m after seven 1.5 h 
exposures to the same simulated altitude. Further, no endurance performance 
enhancements in NH, FiO2 = 12% or 4200 m, were observed following either a shorter (4 
h ∙ d-1 x 4 d) (Debevec & Mekjavic, 2012) or more prolonged (1 h ∙ d-1 x 5 d ∙ wk-1 x 4 
wk) (Mekjavic et al., 2012) protocols. Though the empirical evidence may be limited, the 
results have been consistent in that IHE during rest does not augment endurance 
50 
 
performance in hypoxia; yet, it is by no means conclusive (M Burtscher et al., 2008; 
Faulhaber et al., 2012; Muza, 2007; Muza, Fulco, & Beidleman, 2009).  
 The final altitude training strategy to be discussed is the Live low-Train high 
(LLTH) method, which may also be referred to as IHT. IHT allows the individuals to live 
at or near SL while conducting some or all of their training sessions in simulated NH or 
HH. IHT sessions are approximately 5-180 min in duration (Gregoire P Millet et al., 
2010; Wilber, 2007a) with the severity of altitude ranging from approximately 2000-5500 
m (Bonetti & Hopkins, 2009; Gregoire P Millet et al., 2010; Wilber, 2001, 2007a). IHT 
may be preferable to the previously mentioned altitude training strategies by eliminating 
the majority of the potentially burdensome aspects of the LHTH and/or LHTL strategies. 
Some prospective benefits of utilizing IHT would be the additional time spent in 
normobaric normoxia (NN) for rest and recovery purposes between training sessions 
(Hendriksen & Meeuwsen, 2003) as well eliminating any potential lean body mass 
reductions that may occur with prolonged stays at altitude (Mizuno, Savard, Areskog, 
Lundby, & Saltin, 2008; Zaccagni et al., 2014). Further, IHT may also reduce the burden 
of monetary and time resources that more traditional altitude training methods require 
(Raphaël Faiss et al., 2013; Michael J Hamlin et al., 2013). Finally, and possibly the 
strongest argument to be made in favor of IHT is the preservation of high-intensity 
training sessions. By only conducting some training sessions each week in the simulated 
hypoxic conditions, athletes’ regular training patterns may be maintained, thus drastically 
reducing the risk of a downturn in overall training volume (Dufour et al., 2006; Hoppeler, 
Klossner, & Vogt, 2008; Ponsot et al., 2006). However, despite these perceived 
advantages of IHT, enhanced performance was the original and remains the primary 
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objective of such endurance training practices; therefore, it should be noted that only a 
minute number of studies utilizing a control group have reported significant endurance 
performance enhancements for the IHT group compared to their control group 
counterparts (Raphaël Faiss et al., 2013). 
 Based on the current literature, it does not appear that true IHT sessions, during 
which exercise is performed the entire duration of the exposure to simulated altitude, are 
sufficient to stimulate a sustained HVR or other markers of ventilatory acclimatization. In 
one of the seminal works in this area, it was reported that untrained participants 
performing cycle ergometer training for 30 min ∙ d-1 x 6 d ∙ wk-1 x 4 wk at neither 2250 m 
nor 3450 m significantly increased maximal VE over the SL control group during 
maximal exercise testing at either altitude (Roskamm et al., 1969). Yet, more recent 
results point to the contrary. While neither PetO2 nor PetCO2 was significantly different 
between the control and experimental groups of healthy, untrained individuals at either 
pre- or post-testing, there was a significant difference in the HVR as a result of a slight 
increase in HVR for the IHT group and a significant decrease in HVR for the control 
group following 30 min ∙ d-1 x 5 d ∙ wk-1 x 2 wk of cycle ergometer training in a HH 
setting equivalent to 4500 m. However, after a 2 wk detraining period, the differences in 
HVR dissipated and were no longer significant (Katayama et al., 1999). Furthermore, 
IHT may not only appear to be an insufficient stimulus for ventilatory acclimatization, it 
may also be detrimental to ventilatory acclimatization. Upon completion of a  1 h ∙ d-1 x 6 
consecutive days at the HH equivalent to 4500 m during which the control group 
remained sedentary and the experimental group performed bicycle ergometer exercise for 
30 min of the 1 h exposure sessions, the control group demonstrated an increase in SaO2 
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twice that of the IHT group, 14% versus 7%. Further, the authors also reported that the 
control group displayed a significant resting HVR increase of 30%, whereas the IHT 
group displayed no change in HVR (Katayama et al., 1998). As a result of the deleterious 
effects of IHT reported in the aforementioned study, it has been suggested that if IHT is 
to be performed in an attempt to augment performance at altitude, there should be an 
accompanying duration of IHE that is sufficient to stimulate ventilatory acclimatization 
(Muza, 2007).  
 The empirical evidence of IHT protocols to elicit the hematological adaptations 
commonly associated with altitude training is minimal and remains inconclusive. Several 
investigations, as reported in multiple comprehensive reviews of altitude training 
strategies including IHT, have reported no significant differences in blood parameters 
often associated with aerobic capacity such as serum EPO, Hbcon, Hbmass, Hct, and RBC 
volume (Gregoire P Millet et al., 2010; Muza, 2007; Wilber, 2007a). Based on the current 
literature, it does not appear that there is any difference between NH- and HH-based 
protocols to stimulate erythropoiesis. Further, the current findings appear to be in line 
with prior works that have proposed that 2 h may be the minimal duration necessary to 
stimulate an increase in EPO (Rasmussen et al., 2013) as well as approximating the half-
life of serum EPO to be less than 6 h, thus, current IHT practices would be an insufficient 
stimulus for the initiation of erythropoiesis (Hahn et al., 2001).  
 In one of the more influential works investigating IHT, the authors analyzed the 
effects of 60-90 min ∙ d-1 x 4-5 d ∙ wk-1 x 3-4 wk in 8 competitive cyclists and reported no 
significant differences of Hbcon or Hct, neither between the experimental and control 
groups, nor from pre- to post-testing values (Terrados, Melichna, Sylvén, Jansson, & 
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Kaijser, 1988). Further, a 1 h ∙ d-1 x 3 d ∙ wk-1 x 3 wk protocol utilizing the HH equivalent 
of 4000 m failed to elicit any hematological changes in elite triathletes (Vallier, Chateau, 
& Guezennec, 1996). Further, a lengthier protocol of 30 min ∙ d-1 x 3 d ∙ wk-1 x 6 wk in 
HH equivalent to 3200 m also yielded no significant differences in Hbcon, Hct, or RBC 
count in highly-trained cyclists (N. Ventura et al., 2003). However, there is limited 
evidence that IHT may indeed bring about hematological adaptations. One of the few 
studies of IHT to report hematological parameter increases utilized a cross-over design 
and was conducted using 16 triathletes competing at either the national and international 
levels. The investigators reported a significant difference in Hct between the HH group 
and the control group 9 d after the completion of the 105 min ∙ d-1 x 10 consecutive days 
design in HH equal to 2500 m. Interestingly, the authors also reported significant 
increases in Hbcon, which the authors state could not be accounted for via a decline in PV, 
for both the HH and control groups 2 d after completion of the training, but not after 9 d 
(Hendriksen & Meeuwsen, 2003).    
 NH-based IHT protocols have fared much the same as HH-based IHT methods to 
enhance the O2-carrying capacity of blood.  A 5 wk double-blind, high-intensity training 
program in NH, FiO2 = 15.3% or 2500 m, failed to elicit significant changes in either Hb 
or Hct in trained swimmers (Truijens, Toussaint, Dow, & Levine, 2003). A 30 min ∙ d-1 x 
3 d ∙ wk-1 x 4 wk protocol using cycle ergometer training at an NH equivalent of 2750 m 
on trained team sport athletes was insufficient to produce any changes in either Hbcon or 
Hct (Morton & Cable, 2005).  Further, an examination of the effects of 6 wk of high-
intensity and moderate duration IHT, FiO2 = 14.5% or 3000 m, did not educe Hbcon or 
Hct in highly-trained runners (Dufour et al., 2006).  Another research team also utilizing 
54 
 
the NH equivalent of 3000 m, reported no significant changes in serum EPO, Hbcon, Hct, 
or RBC volume in trained cyclists and triathletes after a 115 min ∙ d-1 x 2 d ∙ wk-1 x 7 wk 
IHT protocol (Roels et al., 2005).  
 In terms of cardiovascular adaptations following IHT, the empirical evidence 
remains scarce, as a minimal number of IHT inquiries have reported such information 
and the available data tend to indicate no significant changes. Multiple studies utilizing 
simulated altitude severities ranging from 2300-4000 m during IHT protocols reported no 
significant changes in HRmax for either normoxic or hypoxic testing conditions following 
either HH- (Hendriksen & Meeuwsen, 2003; Terrados et al., 1988; Vallier et al., 1996) or 
NH-based training (Dufour et al., 2006). Further, a previous inquiry into the 
cardiovascular response upon completion of IHT revealed no significant changes within 
or between the IHT and IHE groups for resting systolic or diastolic blood pressure 
measures, or resting HR (Katayama et al., 2000). Still, the combination of IHE and IHT 
may prove beneficial in terms of submaximal performance as 6 mountaineers displayed 
significant decreases in HR at submaximal but not maximal intensities following the 
completion of 3-5 h ∙ d-1 x 17 d protocol in an HH setting equivalent to 4000-5500 m (M. 
VENTURA, JORDI, & FERRAN, 2000). 
 The efficacy of IHT to enhance aerobic performance at or near SL has been 
extensively researched with inconsequential results to date (Raphaël Faiss et al., 2013), 
however, the efficacy of IHT to improve aerobic performance at moderate to high 
altitudes remains somewhat limited and inconclusive (Muza, 2007). Although, there is a 
trend within the available literature that suggest current IHT practices may be adequate to 
lead to significant submaximal, but not maximal, aerobic endurance performance 
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increases at altitudes above 1500 m. For instance, a 40 min ∙ d-1 x 2 d ∙ wk-1 x 8 wk IHT 
protocol utilizing highly trained runners in an NH setting, FiO2 = 16% or 2150 m, 
reported a significant decrease in both submaximal HR and VO2 after IHT but not after 
normoxic training. Further, the authors also reported no changes in HRmax or VO2max 
between the IHT and control groups after the 8 wk intervention (Holliss, Burden, Jones, 
& Pedlar, 2014). Interestingly, the aforementioned findings appear to be in line with 
previously reported results from a shorter, 3 wk vs 8 wk,  protocol utilizing a more severe 
degree and different form of hypoxia, NH equivalent of 2150 m vs HH equivalent of 
4000 m (Vallier et al., 1996). Additional results from studies that have conducted testing 
under hypoxic conditions have indicated both significant (Roskamm et al., 1969) and 
nonsignificant improvements in VO2max (Hendriksen & Meeuwsen, 2003) as well as 
significant increases in hypoxic work capacity (Terrados et al., 1988) following HH-
based IHT protocols. Equivocal results have also been reported for the limited number of 
investigations performing NH-based IHT protocols that also included NH testing as some 
have described significant improvements to VO2max (Dufour et al., 2006) or aerobic 
power during incremental cycling tests to exhaustion (Roels, Bentley, Coste, Mercier, & 
Millet, 2007). Yet, additional results signified no change to VO2max during testing in NH 
settings (Roels et al., 2007) following IHT compared to normoxic training.  
 While the more traditional altitude training methods such as LHTH and LHTL 
have received greater attention, both from an anecdotal and empirical evidence 
standpoint, the evidence supporting or refuting the effectiveness of more contemporary 
altitude training methods such as IHE and IHT to elicit not only altitude acclimatization 
but also aerobic performance enhancement under hypoxic conditions remains both 
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limited and inconclusive (Michael J Hamlin et al., 2013; Wilber, 2007a). Further, despite 
the increase in commercially available products for NH-based IHE and IHT practices, 
there remains a dearth of evidence of the effectiveness of NIHT to improve aerobic 
performance in an HH setting (Muza, 2007). There are a number of potential reasons for 
the inconclusive results to date related to altitude training, and more specifically, IHT, 
including but not restricted to, methodological and individual variances. As a result, it 
appears there is a necessity for further research in an attempt to provide a better 
understanding of the interaction of IHT methodologies including, but not limited to, 
exposure duration, simulated altitude severity, training intensity, and individual 
differences and their subsequent, combined effect on the hematological, cardiovascular, 
and maximal aerobic capacity variables related to submaximal and maximal aerobic 
performance in environmental altitude above 1500 m (Michael J Hamlin et al., 2013; B. 
D. Levine, 2002; Gregoire P Millet et al., 2010; Muza, 2007; Wilber, 2007a). 
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CHAPTER III 
 
METHODOLOGY 
Subjects 
 Eleven healthy, nonsmoking, college-aged male subjects (age 19.55 ± 1.44 y, 
mass 75.80  ± 8.82 kg, stature 177.45 ± 6.67 cm) with no history of respiratory disease 
participated in this study. Prior to participation, volunteers were fully informed of study 
procedures, risks, and benefits and completed an Institutional Review Board (IRB) 
approved informed consent document. Participants also completed a physical activity 
readiness questionnaire. All participants were current  members of the Oklahoma State 
University (OSU) Army or Air Force ROTC detachments. Prior to and throughout the 
course of the study, all subjects resided in a location approximately 300 m above sea 
level. All potential participants were required to undergo a screening process that also 
served as the normoxic pre-testing procedures. For those participants that met the 
minimum peak aerobic capacity (VO2peak)  standards set forth in the informed consent 
document, their pre-screening results also served as their baseline measurements. As part 
of the pre-screening process, all potential participants completed a VO2peak treadmill 
ergometer test in normoxic conditions (VO2N-pre) using a modified Astrand-Saltin 
protocol (Chapman et al., 1998). A total of 27 ROTC cadets provided notification of their 
desire to participate in this study. Of these 27 potential participants, 20 completed the 
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pre-screening process, with 17 participants achieving a qualifying VO2N-pre of at least 
49.2 mL ∙ kg-1 ∙ min-1. This minimum standard utilized for participant selection purposes 
was chosen due to its usage as the minimum VO2peak of young men considered to be in 
the “excellent” category according to the American College of Sports Medicine (ACSM) 
Guidelines for Exercise Testing and Prescription (Thompson, 2010). Of the three 
potential participants that were not invited to continue their participation, two did not 
meet the minimum aerobic capacity standard and one was excluded due to the existence 
of a lower body injury. The remaining 17 participants were then notified of their selection 
to participate and scheduled to complete the remaining pre-testing procedures. Between 
the time of the VO2N-pre tests and the initial VO2peak treadmill ergometer test in the HH 
chamber (VO2HH-pre), 4 participants provided notification of their desire to end their 
participation in this study. Therefore, a total of 13 participants completed all  aspects of 
the pre-testing procedures (Figure 1). These 13 participants were then pair-wise matched 
based on VO2N-pre results and assigned to either the experimental (n = 8; EXP) or control 
(n = 5; CON) groups. During the course of the training intervention period, 2 participants 
withdrew from the study due to injury unrelated to the study (n = 1) and other 
commitments (n = 1). An independent samples t-test was performed in SPSS and 
determined that the groups’ VO2N-pre results, EXP = 61.53 and CON = 61.96 mL ∙ kg
-1 ∙ 
min
-1
, were not significantly different (P > .05). All subjects were instructed a to maintain 
their current dietary and sleeping habits and also completed weekly physical activity logs.  
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Figure 2. Recruitment of participants 
Assessed for initial eligibility  
(n = 191) 
Excluded (n = 164) 
 Declined to participate 
 Not meeting inclusion 
criteria 
 Other 
Potential Participants (n = 27) 
Excluded (n = 7) 
 Declined to participate  
(n = 7) 
 
Screening Process (n = 20) 
Excluded (n = 7) 
 Declined to participate  
(n = 4) 
 Did not meet VO2max 
requirement (n = 2) 
 Lower body overuse 
injury (n = 1) 
 
Initial Participants  (n = 13) 
Excluded (n = 2) 
 Lower body overuse 
injury (n = 1) 
 Other (n = 1) 
 
Final Participants (n = 11) 
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Pre-Testing Procedures 
Anthropometry 
 All participants underwent height and weight measurements. Both measurements 
were taken utilizing a Detecto Weigh Beam Eye-Level physician scale (Detecto Scale 
Company, Webb City, MO). The scale was calibrated prior to each use. Next, participants 
underwent a 7-site skinfold measurement test to analyze body composition. All skinfold 
measurements were performed by the primary investigator operating a Lange Skinfold 
Caliper (Beta Technology Incorporated, Cambridge, MD). Measurements were taken at 
the triceps, pectoral, midaxillary, subscapular, abdomen, suprailiac, and thigh locations 
and in that same order. A minimum of two measurements were taken at each skinfold site 
and the average of the two measurements was recorded. If there was a difference greater 
than ± 1mm between the initial two measurements, a third measurement was then taken 
and the average of the three measurements was recorded. 
Hematological Measurements 
 Upon notification of selection to become a full participant in this study, all 
participants  underwent an initial blood draw completed by OSU Health Services 
(OSUHS) employees at the OSUHS laboratory. Participants were provided 
documentation (Appendix H) to present to OSUHS employees to verify their 
participation in this study and to ensure that all accompanying costs were charged to the 
project’s grant account. All participants completed the initial blood draw prior to their 
completion of the VO2HH-pre test. A complete blood count (CBC) analysis was performed 
by OSUHS laboratory technicians utilizing a Sysmex XS-1000i Automated Hematology 
Analyzer (Sysmex America, Inc., Lincolnshire, Illinois) to determine baseline measures 
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for the following variables: RBC volume, Hct volume, and Hb levels. Additional analysis 
was performed by Laboratory Corporation of America (Burlington, NC) to establish 
reference values of serum EPO for all participants utilizing the 
immunochemiluminometric assay (ICMA) methodology. 
Normobaric Normoxia Maximal Aerobic Capacity 
 All potential participants completed a maximal aerobic capacity treadmill 
ergometer test in a normoxic setting (VO2N-pre; PB, E 744 mm Hg; FiO2, 20.9%; Average 
temperature, 22.46° C; Average humidity, 42.23%) following a modified Astrand-Saltin 
protocol, a graded maximal aerobic capacity test consisting of 2-min stages (Table 1).  
Table 1. Modified Astrand-Saltin protocol 
Stage Duration (sec) Speed (km/h) Pace (min/km) Gradient (%) 
Warm-up 300 9.66 6.21 0 
1 120 14.48 4.14 0 
2 120 14.48 4.14 2 
3 120 14.48 4.14 4 
4 120 14.48 4.14 6 
5 120 14.48 4.14 8 
6 120 14.48 4.14 10 
Cool-down 120 2.41 24.90 0 
  
 Participants were instructed to abstain from strenuous exercise within 24 h of 
scheduled testing time as well as avoid caffeine consumption within 6 h of testing 
appointments. Prior to the commencement of the Astrand-Saltin protocol, arterial O2 
saturation as measured via pulse oximetry (SpO2) was measured. The potential 
participants then completed a 5 min warm-up during which they ran on the treadmill 
ergometer at a speed of 6.0, the equivalent of a 10-min mi pace, and an incline gradient of 
0%. Upon the completion of the warm-up, the testing protocol began and the treadmill 
ergometer speed increased  to 9.0, the equivalent of a 6:40-min mi pace, while the incline 
gradient remained at 0%. The treadmill remained at this speed the duration of the test. At 
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the beginning of the second stage and each stage thereafter, the incline gradient increased 
by an amount of 2% until the participant reached exhaustion and ended the test. Upon the 
completion of the testing protocol, participants then completed a 2 min active recovery 
during which they walked on the treadmill at a speed of 1.5, the equivalent of a 40-min 
mi pace, and an incline gradient of 0%. All tests were completed on a Trackmaster 
treadmill  (TMX 425C, Newton, KS) and expired gases were analyzed using a 4-breath 
average through a mixing chamber via a calibrated TrueOne® 2400 metabolic measuring 
system  (Parvo Medics, Salt Lake City, UT). Per the work performed by Savourey et al. 
(2003), all volume measurements from VO2max assessments were recorded under the body 
temperature pressure saturated (BTPS) condition. Additionally, HR was continuously 
monitored and maximum HR (HRmax) was recorded  using a Polar HR monitor (Polar 
Electro FT1 and T31, Lake Success, NY). All subjects achieved at least two of the 
following criteria had been achieved: a plateau of O2 consumption defined as a rise of 
less than 2 mL ∙ kg-1 ∙ min-1 between the final stages, a respiratory exchange ratio (RER) 
of 1.1 or greater, a blood lactate (BL) concentration ≥ 8.0 mmol/L, and HRmax within ± 
10 beats/min of their age-predicted HRmax to meet the assumptions of a true maximal 
aerobic capacity test. The following variables from all normoxic and hypobaric hypoxic 
VO2peak tests were recorded and analyzed: HRmax (BPM) time-to-exhaustion (TE; min), 
peak oxygen uptake (VO2peak; L ∙ min
-1
), peak carbon dioxide production (VCO2; L/min), 
relative peak oxygen uptake (RVO2peak; mL ∙ kg
-1 ∙ min-1), minute ventilation (VE; L ∙ 
min
-1 – BTPS), tidal volume (VT; L ∙ min
-1
), breathing frequency (f; breaths per minute), 
end-tidal oxygen pressure (PetO2; mmHg), and end-tidal carbon dioxide pressure 
(PetCO2; mmHg). 
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Hypobaric Hypoxia Maximal Aerobic Capacity 
 Participants who met the VO2peak  minimum requirements during the pre-
screening process in the normoxic environment then completed a maximal aerobic 
capacity treadmill ergometer test in the HH setting (VO2HH-pre; Average PB, E 537.23 mm 
Hg; FiO2, 20.9%; Average temperature, 26° C; Average humidity, 53.85%) at the OSU 
Center for Health Sciences (OSU-CHS) Center for Aerospace and Hyperbaric Medicine 
following a 2-7 d rest period after the VO2N-pre tests. Participants were instructed to 
abstain from strenuous exercise within 24 h of scheduled testing time as well as avoid 
caffeine consumption within 6 h of testing appointment. Prior to entering the HH 
chamber, all participants underwent blood pressure (BP), body temperature, and pulse 
readings performed by a RN. Participants then entered the HH chamber on an individual 
basis via an altitude elevator that was attached to the HH chamber, thus ensuring that the 
amount of simulated altitude exposure remained consistent for each participant prior to 
the start of each VO2HH-pre test. Approximately 5 min after entering the HH chamber, 
SpO2 was measured. The same modified Astrand-Saltin protocol, as described in the 
previous paragraph and presented in Table 1, was utilized to carry out the VO2HH-pre 
testing. The test was completed on a Trackmaster treadmill (TMX 425C, Newton, KS) 
and expired gases were analyzed using a 4-breath average through a mixing chamber via 
a calibrated TrueOne® 2400 metabolic measuring system  (Parvo Medics, Salt Lake City, 
UT).  Per the work performed by Savourey et al. (2003), all volume measurements from 
VO2max assessments were recorded under the BTPS condition. Additionally, HR was 
continuously monitored and HRmax was recorded  using a Polar HR monitor (Polar 
Electro FT1 and T31, Lake Success, NY). All subjects achieved at least two of the 
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following criteria had been achieved: a plateau of O2 consumption defined as a rise of 
less than 2 mL ∙ kg-1 ∙ min-1 between the final stages, an RER of 1.1 or greater, a BL 
concentration ≥ 8.0 mmol/L, and HRmax within ± 10 beats/min of their age-predicted 
HRmax to meet the assumptions of a true maximal aerobic capacity test. A board certified 
doctor of osteopathic medicine (DO) was present in the HH chamber for all VO2max tests 
carried out in the hypobaric chamber. Upon exiting the HH chamber, each participant 
underwent BP, body temperature, and pulse readings performed by an RN. 
Intervention Training Protocol 
 All subjects performed identical training protocols (Table 2) on Trackmaster 
TMX425 treadmill ergometers (Full Vision Inc., Kansas, USA), with the CON group 
performing the training sessions in a normoxic setting and the EXP group performing all 
training sessions in NH at a simulated altitude of 2750 m (FiO2 = 15%).  
Table 2. Intervention training protocol 
 Warm-Up Cardiovascular 
Training 
Cool-Down 
Week Duration 
(min) 
Intensity 
(%HRmax) 
Duration 
(min) 
Intensity 
(%HRmax) 
Duration 
(min) 
Intensity 
(%HRmax) 
1 NA NA 60 50-60% NA NA 
2 10 50-60% 40 60-70% 10 50-60% 
3 10 50-60% 40 70-77% 10 50-60% 
4 10 50-60% 40 70-77% 10 50-60% 
5 10 50-60% 10 
20 
10 
60-70% 
78-85% 
60-70% 
10 50-60% 
6 10 50-60% 10 
20 
10 
60-70% 
78-85% 
60-70% 
10 50-60% 
  
 All normobaric hypoxic equipment was manufactured by Hypoxico Altitude 
Training Systems (New York, NY). As this research project was conducted with a single-
blind experimental protocol in an attempt to reduce any nocebo effect, both the CON and 
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EXP groups completed the training sessions while wearing the High Altitude Training 
Masks (training masks). However, only the EXP participants’ training masks (Figure 3) 
were connected to the Everest Summit II Altitude Generator (altitude generator).  
 
Figure 3. EXP group training mask setup 
 
 Normobaric hypoxic conditions for the EXP group was simulated by diluting 
ambient air with nitrogen via the altitude generator. CON participants’ training masks 
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were not connected to the altitude generator, thus allowing them to train under normoxic 
conditions (Figure 4).  
 
Figure 4. CON group training mask setup 
 
 Participants were allowed to adjust the speed of the treadmill ergometer ad 
libitum so as to keep their HR within the prescribed HR ranges during the warm-up, 
exercise, and cool-down portions of each training session. The  incline gradient of the 
treadmill ergometer was set to 2% for the duration of all training sessions. Prior to each 
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training session, each participant received their training prescription cards for the day and 
any necessary clarifications were provided prior to the start of the training session. 
Participants were then fitted with Polar HR monitors (Polar Electro FT1 and T31, Lake 
Success, NY) and the training masks. Training intensity for both groups was determined 
via a percentage of the HRmax achieved during the VO2N-pre for the CON group and 
VO2HH-pre  for the EXP group, respectively. The percentage of HRmax has been shown to 
be highly correlated to its respective percentage of VO2max and thus an appropriate 
method for determining training intensities (Reis, Van den Tillaar, & Marques, 2011).  
 The training intervention was 6 wk in duration, with three 1 h training sessions 
per week for a total of 18 training sessions. All 3 training sessions during week 1 
consisted of 60 min at 50-60% of VO2peak as determined by  VO2N-pre for the CON group 
and VO2HH-pre  for the EXP group, respectively. The 3 training sessions during the second 
week of the intervention period consisted of a 10 min warm-up and 10 min cool-down, 
both performed at 50-60% of VO2N-pre for the CON group and VO2HH-pre  for the EXP 
group, respectively. The work portion of all training sessions during week 2 was 40 min 
in duration with the intensity prescribed as 60-70% of VO2N-pre for the CON group and 
VO2HH-pre  for the EXP group, respectively. Training sessions for weeks 3 & 4 consisted 
of a 10 min warm-up and 10 min cool-down, both performed at 50-60% of VO2N-pre for 
the CON group and VO2HH-pre  for the EXP group, respectively. The work portion of all 
training sessions during weeks 3 and 4 was 40-min in duration with a prescribed intensity 
of 70-77% of VO2N-pre for the CON group and VO2HH-pre  for the EXP group, respectively. 
Training sessions for weeks 5 & 6 consisted of a stair-step design with a 10 min warm-up 
at 50-60%, 10 min at 60-70%, 20 min at 77-85%, 10 min at 60-70%, and 10 min cool-
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down at 50-60% of VO2N-pre for the CON group and VO2HH-pre  for the EXP group, 
respectively. There was a 24-48 h recovery period between each training session. As all 
subjects were current ROTC cadets, each participant continued their participation in their 
mandatory PT sessions throughout the duration of the intervention period. An 
independent samples t-test was performed in SPSS to determine if there were any 
differences in the average amount of time per participant performing PT between the 
CON and EXP groups. Distance travelled, elevation gain, average speed, and SpO2 were 
recorded for all training sessions. In addition, FiO2 was recorded for each training session 
completed by the EXP participants. All  training sessions took place in the OSU Health & 
Human Performance (HHP) Laboratory under the supervision of the primary 
investigators or other HHP graduate assistants who held current cardiopulmonary 
resuscitation (CPR) certifications and had completed the necessary CITI Responsible 
Conduct of Research Training.  
Post-Testing Procedures 
Anthropometry 
 Post-testing procedures occurred 3-4 d after participants had completed their final 
training session. All participants completed a post-intervention weight measurement. 
Weight was taken utilizing a Detecto Weigh Beam Eye-Level physician scale (Detecto 
Scale Company, Webb City, MO). The scale was calibrated prior to each use. Next, 
participants underwent a 7-site skinfold measurement test to analyze body composition. 
All skinfold measurements were performed by the primary investigator operating a Lange 
Skinfold Caliper (Beta Technology Incorporated, Cambridge, MD). Measurements were 
taken at the triceps, pectoral, midaxillary, subscapular, abdomen, suprailiac, and thigh 
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locations and in that same order. A minimum of two measurements were taken at each 
skinfold site and the average of the two measurements was recorded. If there was a 
difference greater than ± 1mm between the initial two measurements, a third 
measurement was then taken and the average of the three measurements was recorded 
and used for analysis. 
Hematological Measurements 
 Participants  underwent a second blood draw completed by OSUHS employees at 
the UHS laboratory. Participants were provided documentation (Appendix H) to present 
to OSUHS employees to verify their participation in this study and to ensure that all 
accompanying costs were charged to the project’s grant account. All participants 
completed the blood draw prior to their completion of the VO2HH-post test. A CBC analysis 
was performed by OSUHS laboratory technicians utilizing a Sysmex XS-1000i 
Automated Hematology Analyzer (Sysmex America, Inc., Lincolnshire, Illinois) to 
determine post-testing measures for the following variables: RBC volume, Hct volume, 
and Hb levels. Additional analysis was performed by Laboratory Corporation of America 
(Burlington, NC) to establish post-intervention values of serum EPO for all participants 
utilizing the ICMA methodology. 
Normobaric Normoxia Maximal Aerobic Capacity 
 Participants completed a maximal aerobic capacity treadmill ergometer test in a 
normoxic setting (VO2N-post; PB, E 744 mm Hg; FiO2, 20.9%; Average temperature, 22.46° 
C; Average humidity, 42.23% ) following the identical modified Astrand-Saltin protocol 
utilized during the pre-testing procedures (Figure 2). Participants were instructed to 
abstain from strenuous exercise within 24 h of scheduled testing time as well as avoid 
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caffeine consumption within 6 h of testing appointment. Prior to the commencement of 
the Astrand-Saltin protocol, SpO2 was measured. The participants then completed a 5 min 
warm-up during which they ran on the treadmill ergometer at a speed of 6.0, the 
equivalent of a 10-min mi pace, and an incline gradient of 0%. Upon the completion of 
the warm-up, the testing portion began and the treadmill ergometer speed increased  to 
9.0, the equivalent of a 6:40-min mi pace, while the incline gradient remained at 0%. The 
treadmill remained at this speed the duration of the test. At the beginning of the second 
stage and each stage thereafter, the incline gradient increased by an amount of 2% until 
the participant reached exhaustion and ended the test. Upon the completion of the testing 
protocol, participants then completed a 2 min active recovery during which they walked 
on the treadmill at a speed of 1.5, the equivalent of a 40-min mi pace, and an incline 
gradient of 0%. The test was completed on a Trackmaster treadmill  (TMX 425C, 
Newton, KS) and expired gases were analyzed using a 4-breath average through a mixing 
chamber via a calibrated TrueOne® 2400 metabolic measuring system  (Parvo Medics, 
Salt Lake City, UT).  Per the work performed by Savourey et al. (2003), all volume 
measurements from VO2max assessments were recorded under the BTPS condition. 
Additionally, HR was continuously monitored and HRmax was recorded  using a Polar HR 
monitor (Polar Electro FT1 and T31, Lake Success, NY). All subjects achieved at least 
two of the following criteria had been achieved: a plateau of O2 consumption defined as a 
rise of less than 2 mL ∙ kg-1 ∙ min-1 between the final stages, a RER of 1.1 or greater, a BL 
concentration ≥ 8.0 mmol/L, and HRmax within ± 10 beats/min of their age-predicted 
HRmax to meet the assumptions of a true maximal aerobic capacity test. 
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Hypobaric Hypoxia Maximal Aerobic Capacity 
 Participants also completed a VO2max treadmill ergometer test in the HH chamber 
(VO2HH-post; Average PB, E 537.23 mm Hg; FiO2, 20.9%; Average temperature, 26° C; 
Average humidity, 53.85%) at the OSU-CHS Center for Aerospace and Hyperbaric 
Medicine following a 3 d rest period. Participants were instructed to abstain from 
strenuous exercise within 24 h of scheduled testing time as well as avoid caffeine 
consumption within 6 h of testing appointment. Prior to entering the HH chamber, all 
participants underwent BP, body temperature, and pulse readings performed by an RN. 
Participants then entered the HH chamber on an individual basis via an altitude elevator 
that was attached to the HH chamber, thus ensuring that the amount of simulated altitude 
exposure remained consistent for each participant prior to the start of each VO2HH-post test. 
Approximately 5 min after entering the HH chamber, SpO2 was measured. The same 
modified Astrand-Saltin protocol, as described previously, and presented in Figure 2, was 
utilized to carry out the VO2HH-post testing. The test was completed on a Trackmaster 
treadmill  (TMX 425C, Newton, KS) and expired gases were analyzed using a 4-breath 
average through a mixing chamber via a calibrated TrueOne® 2400 metabolic measuring 
system  (Parvo Medics, Salt Lake City, UT). Per the work performed by Savourey et al. 
(2003), all volume measurements from VO2max assessments were recorded under the 
BTPS condition. Additionally, HR was continuously monitored and HRmax was recorded  
using a Polar HR monitor (Polar Electro FT1 and T31, Lake Success, NY). All subjects 
achieved at least two of the following criteria had been achieved: a plateau of O2 
consumption defined as a rise of less than 2 mL ∙ kg-1 ∙ min-1 between the final stages, an 
RER of 1.1 or greater, a BL concentration ≥ 8.0 mmol/L, and HRmax within ± 10 
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beats/min of their age-predicted HRmax to meet the assumptions of a true maximal aerobic 
capacity test. A board certified DO was present in the HH chamber for all VO2max tests 
carried out in the hypobaric chamber. Upon exiting the HH chamber, each participant 
underwent BP, body temperature, and pulse readings performed by an RN. 
Follow-up Testing Procedures 
Hematological Measurements 
 Follow-up testing occurred for EXP participants only. Upon completion of a 1 wk 
detraining period, which amounted to two weeks since the completion of participants’ 
final IHT exposure,  EXP participants underwent a third and final blood draw completed 
by OSUHS employees at the OSUHS laboratory. Participants were provided 
documentation (Appendix H) to present to OSUHS employees to verify their 
participation in this study and to ensure that all accompanying costs were charged to the 
project’s grant account. All EXP participants completed the blood draw prior to their 
completion of the VO2HH-FollowUp test.   A CBC analysis was performed by OSUHS 
laboratory technicians utilizing a Sysmex XS-1000i Automated Hematology Analyzer 
(Sysmex America, Inc., Lincolnshire, Illinois) to determine follow-up quantities for the 
following variables: RBC volume, Hct volume, and Hb levels. Additional analysis was 
performed by Laboratory Corporation of America (Burlington, NC) to establish follow-
up values of serum EPO for EXP participants utilizing the ICMA methodology. 
Hypobaric Hypoxia Maximal Aerobic Capacity 
 EXP participants (n = 6) completed a third and final VO2max treadmill ergometer 
test in the HH chamber (VO2HH-FollowUp; Average PB, E 537.23 mm Hg; FiO2, 20.9%; 
Average temperature, 26° C; Average humidity, 53.85%) at the OSU-CHS Center for 
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Aerospace and Hyperbaric Medicine following a 1 wk detraining period, which 
established a 2 wk period between the final IHT exposure and the VO2HH-FollowUp tests. 
Participants were instructed to abstain from strenuous exercise within 24 h of scheduled 
testing time as well as avoid caffeine consumption within 6 h of testing appointment. 
Prior to entering the HH chamber, all participants underwent BP, body temperature, and 
pulse readings performed by an RN. Participants then entered the HH chamber on an 
individual basis via an altitude elevator that was attached to the HH chamber, thus 
ensuring that the amount of simulated altitude exposure remained consistent for each 
participant prior to the start of each VO2HH-FollowUp test. Approximately 5 min after 
entering the HH chamber, SpO2 was measured. The same modified Astrand-Saltin 
protocol as was used for the pre- and post-testing procedures was utilized for the VO2HH-
FollowUp testing. At the commencement of the recovery period, SpO2 measurements were 
performed. The test was completed on a Trackmaster treadmill (TMX 425C, Newton, 
KS) and expired gases were analyzed using a 4-breath average through a mixing chamber 
via a calibrated TrueOne® 2400 metabolic measuring system (Parvo Medics, Salt Lake 
City, UT). Per the work performed by Savourey et al. (2003), all volume measurements 
from VO2max assessments were recorded under the BTPS condition. Additionally, HR was 
continuously monitored and HRmax was recorded  using a Polar HR monitor (Polar 
Electro FT1 and T31, Lake Success, NY). All subjects achieved at least two of the 
following criteria had been achieved: a plateau of O2 consumption defined as a rise of 
less than 2 mL ∙ kg-1 ∙ min-1 between the final stages, an RER of 1.1 or greater, a BL 
concentration ≥ 8.0 mmol/L, and HRmax within ± 10 beats/min of their age-predicted 
HRmax to meet the assumptions of a true maximal aerobic capacity test. A board certified 
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DO was present in the HH chamber for all VO2max tests carried out in the hypobaric 
chamber. Upon exiting the HH chamber, each participant underwent BP, body 
temperature, and pulse readings performed by an RN. 
Statistical Analysis 
 Descriptive data will be presented  as means ± standard deviation (SD) for 
participant characteristics and all testing variables. Mixed analysis of variance (ANOVA) 
will be performed on all variables to analyze differences between the within-subjects 
factor (time) and between-subjects factor (CON and EXP). Repeated measures ANOVA 
will be performed to analyze differences for all variables between the pre-, post-, and 
follow-up results of the EXP group. Significant main effects and interactions will be 
analyzed using Bonferroni correction. The level of statistical significance will be set at p 
< 0.05. Statistical analysis will be conducted using SPSS version 21. 
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CHAPTER IV 
 
RESULTS 
Subject Characteristics 
 There were no significant differences between the EXP and CON groups for 
height or age, P = 0.12 and P = 0.60, respectively. There was neither a significant main 
effect of time F(1,8) = 0.29, P = 0.60, nor training group of participants F(1,9) = 0.89, P = 
0.37, nor was there a significant interaction of time x training group of the participants, 
F(1,9) = 0.12, P = 0.73 for BM. There was no significant main effect of time F(1,9) = 
1.53, P = 0.25, nor training group of participants F(1,9) = 0.001, P = 0.98, nor was there a 
significant interaction of time x training group of the participants, F(1,9) = 3.11, P = 0.11 
on the body fat percentages (BF%) of participants. 
Table 3. Subject characteristics (Mean ± SD) 
 CON EXP 
Variable Pre-test Post-test Pre-test Post-test 
Height (cm) 178.7 ± 8.17 N/A 176.42 ± 5.71 N/A 
Body mass (kg) 78.59 ± 11.88 78.54 ± 12.25 73.54 ± 5.34 73.27 ± 5.73 
Age (y) 18.80 ± 1.79 N/A 20.17 ± .75 N/A 
Body fat (%) 8.59 ± 3.07 8.82 ± 3.68 9.43 ± 3.67 8.10 ± 2.83 
N = 11 (CON, n = 5; EXP, n = 6) unless otherwise stated. 
Training Volume 
 There was no significant difference between groups in training time (min) 
performed during PT, P = 0.56. Based on independent samples t-tests, there was no 
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significant difference in the average distance completed per training session (km) 
between groups for Week 1; however, the CON group completed significantly more km 
per training session during Week 2, 3.87 vs 3.58 km, P = 0.005, Weeks 3 & 4, 4.17 vs 
3.92 km,  P = 0.014, and Weeks 5 & 6, 4.22 vs 3.86 km, P = 0.002 (Table 4). Further, the 
average SpO2 was, on average, significantly less in the EXP group than the CON group 
during each training session during Week 1, 84.79 vs 97.11%, P < 0.001, Week 2, 82.35  
vs 96.85%, P < 0.001, Weeks 3 & 4, 82.30 vs 97.11%, P < 0.001, and Weeks 5 & 6, 
84.24 vs 97.54%, P < 0.001 (Figure 5).  
Table 4. Intervention protocol training volume (Mean ± SD) 
   Week 1 
Per Session 
Week 2 
Per Session 
Weeks 3 & 4 
Per Session 
Weeks 5 & 6 
Per Session Totals 
Distance 
Covered 
(km) 
E 5.13 ± .58 5.76 ± .37^ 6.30± .5* 6.22 ± .77^ 95.9 
C 5.08 ± .47 6.23 ± .46 6.71 ± .62 6.79 ± .57 109.7 
SpO2 
(50 min) 
E 84.8 ± 3.16^ 82.36 ± 2.68^ 82.3 ± 2.68^ 84.2 ± 2.15^ 82.4 
C 97.1 ± 1.27 96.85 ± 1.76 97.11 ± 1.13 97.54 ± .58 97.2 
Average 
Pace 
(min/km) 
E 11:41 10:25 9:31 9:40 10:00 
C 11:49 9:38 8:57 8:50 9:17 
* P < .05, ^ P < .01 for difference with CON. 
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Hematology 
 All hematological variables are summarized in Table 5. A summary of the 
repeated measures analysis of the pre-, post-, and follow-up testing for all hematological 
variables of the EXP group, as only the EXP group completed the follow-up testing 
procedures, is presented in Table 6.  
Erythrocyte Volume 
 
 There was no significant interaction of time x training group of the participants, 
F(1,8) = 0.24, P = 0.64, nor main effect of training group of participants F(1,8) = 4.61, P 
= 0.06, nor was there a significant main effect of time F(1,8) = 0.42, P = 0.54, for RBC 
volume. Further, there was no significant difference at any time (pre-, post-, or follow-up 
testing) in RBC volume for the EXP participants, F(2,1) = 5.68, P = 0.15. 
Hemoglobin Concentration   
 There was no significant interaction of time x training group of the participants, 
F(1,8) = 0.47, P = 0.51, nor was there a significant main effect of training group of 
70
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Figure 5. Training session average SpO2. ^ p < .01, indicates the EXP 
group's SpO2 was significantly lower than CON group. Values are mean ± 
SD. 
EXP (n = 6)
CON (n = 5)
^ 
^ 
^ 
^ 
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participants F(1,8) = 2.99, P = 0.12,  nor was there a significant main effect of time F(1,8) 
= 0.60, P = 0.46, for Hb concentration. Further, there was no significant difference at any 
time (pre-, post-, or follow-up testing) in Hb concentration for the EXP participants, 
F(2,1) = 4.81, P = 0.17. 
Hematocrit  
 There was no significant interaction of time x training group of the participants, 
F(1,8) = 0.14, P = 0.72, nor was there a significant main effect of training group of 
participants F(1,8) = 3.61, P = 0.09, nor was there a significant main effect of time F(1,8) 
= 0.50, P = 0.50, for Hct levels. Further, there was no significant difference at any time 
(pre-, post-, or follow-up testing) in Hct levels for the EXP participants, F(2,1) = 4.51,  
P = 0.18. 
Serum Erythropoietin 
 There was no significant interaction of time x training group of the participants, 
F(1,8) = 0.78, P = 0.40, nor was there a significant main effect of training group of 
participants F(1,8) = 0.64 P = 0.45, nor was there a significant main effect of time F(1,8) 
= 0.00, P = 0.99, for serum EPO levels. Further, there was no significant difference at any 
time (pre-, post-, or follow-up testing) in EPO levels for the EXP participants, F(2,1) = 
0.93, P = 0.52. 
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Table 5. Hematological parameters  
  Pre-test Post-test 
Variable Group Mean ± SD 
95% CI 
Mean ± SD 
95% CI 
Lower Upper Lower Upper 
RBC 
(M/uL) 
EXP  
CON  
Mean 
5.10 ± .38 
4.63 ± .27 
4.86 ± .40 
4.75 
4.29 
4.62 
5.44 
4.97 
5.11 
5.11 ± .46 
4.72 ± .17 
4.91 ± .38 
4.75 
4.36 
4.66 
4.46 
5.07 
5.16 
Hb (g/dL) EXP 
CON 
Mean 
15.2 ± .77 
14.28 ± .69 
14.74 ± .84 
14.44 
13.52 
14.21 
15.96 
15.04 
15.28 
15.22 ± 1.05 
14.6 ± .53 
14.91 ± .85 
14.36 
13.74 
14.30 
16.08 
15.46 
15.52 
Hct (%) EXP 
CON 
Mean 
44.16 ± 2.70 
41.62 ± 1.48 
42.89 ± 2.45 
41.91 
39.37 
41.30 
46.41 
43.87 
44.48 
44.36 ± 2.74 
42.28 ± 1.21 
43.32 ± 2.28 
42.17 
40.09 
41.77 
46.55 
44.47 
44.87 
Serum 
EPO 
(mIU/mL) 
EXP 
CON 
Mean 
8.48 ± 3.62 
12.12 ± 7.65 
10.3 ± 5.96 
2.31 
5.95 
5.94 
14.65 
18.29 
14.67 
9.7 ± 3.80 
10.94 ± 5.01 
10.32 ± 4.24 
5.12 
6.36 
7.08 
14.29 
15.56 
13.56 
N = 10 (EXP, n = 5; CON, n = 5) unless otherwise stated. 
Table 6. EXP group hematological parameters (Mean ± SD) 
Variable Pre-test Post-test Follow-up 
RBC (M/uL) 5.15 ± .42 5.19 ± .48 5.32 ± .38 
Hb (g/dL) 15.25 ± .89 15.3 ± 1.20 15.78 ± .79 
Hct (%) 44.05 ± 3.11 44.7 ± 3.04 45.83 ± 2.21 
Serum EPO (mIU/mL) 9.3 ± 3.61 8.43 ± 2.90 8.35 ± 2.00 
N = 4 unless otherwise stated. 
Normobaric Normoxia Maximal Aerobic Capacity 
Maximum Heart Rate  
 There was no significant interaction of time x training group F(1,8) = 0.38, P = 
0.55, nor was there a significant main effect of time F(1,8) = 0.04, P = 0.84. However, 
there was a significant difference in HRmax measured during NN aerobic capacity pre- 
and post-testing (3.63% and 4%, respectively) between training groups, F(1,8) = 11.87, P 
= 0.01. HRmax and all other normoxic maximal aerobic capacity variables are summarized 
in Table 7. 
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Time-to-Exhaustion  
 There was no significant interaction of time x training group, F(1,8) = 0.56, P = 
0.48, nor significant main effect of training group, F(1,8) = 0.06, P = 0.81, nor significant 
main effect of time F(1,8) = 0.002, P = 0.97, on TE measured during NN aerobic capacity 
testing. 
Maximal Oxygen Uptake 
 There was no significant interaction of time x training group, F(1,8) = 2.03, P = 
0.19, nor was there a significant main effect of training group, F(1,8) = 3.65, P = 0.09. 
However, there was a significant main effect of time F(1,8) = 10.09, P = 0.01 for VO2peak 
as demonstrated by a 5.44% increase from pre- to post-testing measures.  
Relative Maximal Oxygen Uptake 
 There was no significant interaction of time x training group, F(1,8) = 5.18, P = 
0.46, nor was there a significant main effect of training group, F(1,8) = 0.19, P = 0.68. 
However, there was a significant main effect of time F(1,8) = 6.88, P = 0.03 for RVO2peak 
as demonstrated by a 5.31% increase from pre- to post-testing measures. 
Minute Ventilation 
 There was a significant, ordinal interaction of time x training group on VE, F(1,8) 
= 6.29, P = 0.04. Further analysis utilizing a paired samples t-test revealed no difference 
(P = 0.24) in VE for the CON group and a significant (P = 0.04) 3.92% decrease in VE 
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from the pre- to post-testing for the EXP group.  
 
Breathing Frequency 
 There was no significant interaction of time x training group, F(1,8) = 1.61, P = 
0.24,  nor significant main effect of training group, F(1,8) = 0.002, P = 0.97, nor 
significant main effect of time F(1,8) = 0.42, P = 0.54,  f measured during NN aerobic 
capacity testing. 
Tidal Volume 
 There was no significant interaction of time x training group, F(1,8) = 0.07, P = 
0.80, nor significant main effect of training group, F(1,8) = 0.29, P = 0.65, nor significant 
main effect of time F(1,8) = 1.39, P = 0.27, on VT measured during NN aerobic capacity 
testing. 
End-tidal Oxygen Pressure 
 There was no significant interaction of time x training group, F(1,8) = 0.95, P = 
0.36, nor significant main effect of training group, F(1,8) = 1.28, P = 0.29, nor significant 
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Figure 6. NN maximal VE. ǂ p < .05, indicates a significant 
interaction of time x training group.   
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main effect of time F(1,8) = 1.22, P = 0.30, on PetO2 measured during NN aerobic 
capacity testing. 
End-tidal Carbon Dioxide Pressure 
 There was no significant interaction of time x training group, F(1,8) = 1.99, P = 
0.20, nor significant main effect of time F(1,8) = 0.04, P = 0.84, nor significant main 
effect of training group, F(1,8) = 1.28, P = 0.29 on PetCO2 measured during NN aerobic 
capacity testing. 
Arterial Oxygen Saturation  
 There was no significant interaction of time x training group F(1,9) = 0.02, P = 
0.90 on SpO2 levels. There was also no significant main effect of training group F(1,9) = 
0.54, P = 0.48, however, there was a significant main effect of time F(1,9) = 16.95, P = 
0.003 as demonstrated by a 1.89% decrease in mean SpO2 from pre- to post-testing 
assessment in the NN condition.  
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Table 7. Normobaric normoxia VO2 test parameters  
Variable Group 
Pre-test Post-test 
Mean ± SD 
95% CI 
Lower, Upper Mean ± SD 
95% CI 
Lower, Upper 
HRmax  
(BPM) 
EXP 
CON 
Mean 
199.50 ± 1.37 
192.25 ± 4.79 
196.60 ± 4.77 
196.56, 202.44 
196.29, 203.71 
193.55, 198.20 
200.00 ± 1.67 
192.00 ± 6.06 
196.80 ± 5.55 
188.64, 195.87 
187.46, 196.54 
193.07, 198.93 
TE  
(min) 
EXP 
CON 
Mean 
11.23 ± 1.90 
11.64 ± 1.75 
11.39 ± 1.76 
9.49, 12.97 
9.51, 13.78 
10.06, 12.81 
11.36 ± 1.90 
11.50 ± 1.05 
11.41 ± 1.54 
9.82, 12.89 
9.61, 13.38 
10.21, 12.64 
VO2peak  
(L ∙ min -1) 
 
EXP 
CON 
Mean 
5.64 ± .82 
6.26 ± .53 
5.88 ± .76 
4.95, 6.32 
5.42, 7.09 
5.41, 6.49 
5.83 ± .50 
6.76 ± .66 
6.20 ± .72* 
5.3, 6.36 
6.11, 7.41 
5.87, 6.71 
RVO2peak  
(mL ∙ min -1 ∙ kg-1) 
 
EXP 
CON 
Mean 
61.55 ± 7.00 
62.01 ± 3.92 
61.74 ± 5.69 
55.88, 67.23 
55.05, 68.96 
57.29, 66.27 
64.01 ± 5.45 
66.54 ± 5.27 
65.02 ± 5.24* 
58.94, 69.08 
60.34, 72.75 
61.27, 69.28 
VE  
(L ∙ min-1) 
EXP 
CON 
Mean 
134.80 ± 16.95 
136.15 ± 15.70 
135.34 ± 15.57 
119.27, 150.33 
117.13, 155.17 
123.20, 147.75 
129.51 ± 18.20ǂ 
148.61 ± 28.98 
137.15 ± 23.69 
108.00, 151.02 
122.27, 174.95 
122.06, 156.06 
VT  
(L ∙ min-1) 
EXP 
CON 
Mean 
2.73 ± .63 
2.85 ± .24 
2.78 ± .49 
2.24, 3.21 
2.25, 3.45 
2.40, 3.17 
2.84 ± .55 
3.02 ± .55 
2.91 ± .53 
2.32, 3.36 
2.39, 3.66 
2.52, 3.34 
f   EXP 
CON 
Mean 
50.68 ± 7.07 
47.90 ± 5.02 
49.57 ± 6.18 
44.68, 56.69 
40.55, 55.26 
44.54, 54.04 
46.73 ± 8.78 
49.19 ± 3.63 
47.71 ± 6.99 
39.86, 53.59 
40.78, 57.60 
42.53, 53.39 
PetO2  
(mm Hg) 
EXP 
CON 
Mean 
121.35 ± 2.51 
117.99 ± 2.48 
120.01 ± 2.93 
119.00, 123.71 
115.11, 120.87 
117.81, 121.53 
118.84 ± 3.12 
117.83 ± 5.80 
118.43 ± 4.11 
114.76, 122.91 
112.85, 122.82 
115.12, 121.55 
PetCO2  
(mm Hg) 
EXP 
CON 
Mean 
34.45 ± 1.79 
39.24 ± 2.03 
36.37 ± 3.05 
32.68, 36.22 
37.07, 41.41 
35.44, 38.25 
35.60 ± 3.97 
37.69 ± 2.75 
36.44 ± 3.53 
32.24, 38.95 
33.59, 41.80 
33.99, 39.30 
SpO2  
(%) 
EXP 
CON 
Mean 
98.58 ± .66 
98.20 ± .45 
98.41 ± .58 
98.05, 99.12 
97.62, 98.79 
98.00, 98.79 
96.67 ± 1.21 
96.40 ± 1.52 
96.55 ± 1.29^ 
95.42, 97.92 
95.03, 97.77 
95.61, 97.46 
N = 10 (EXP, n = 6; CON, n = 4) unless otherwise stated. 
TE, time-to-exhaustion; VO2peak, maximal oxygen uptake; RVO2peak, relative oxygen 
uptake; VE, minute ventilation (BTPS); Vt, tidal volume; f, breathing frequency; PetO2, 
end-tidal O2 pressure; PetCO2, end-tidal CO2 pressure. 
* P < .05, ^ P < .01 for difference with Pre-test. 
ǂ P < .05 for significant interaction of time x training group.  
Hypobaric Hypoxia Maximal Aerobic Capacity 
 All hypobaric hypoxia maximal aerobic capacity variables are summarized in 
Table 8. A summary of the repeated measures analysis of the pre-, post-, and follow-up 
testing variables of the aerobic capacity tests in the hypobaric hypoxic conditions, as only 
the EXP group completed the follow-up testing procedures, is presented in Table 9.  
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Maximum Heart Rate  
 There was no significant interaction of time x training group F(1,9) = 0.97, P = 
0.35,  partial ή2 = 0.097, nor was there a significant difference between training groups, 
F(1,9) = 2.25, P = 0.17, nor a significant main effect of time F(1,9) = 0.71, P = 0.42, in 
HRmax measured during the hypobaric hypoxia aerobic capacity testing. Further, there 
was no significant difference of HRmax in the EXP group between pre-, post-, and follow-
up assessments in the hypobaric hypoxic chamber, F(2,3) = 0.75, P = 0.53.  
Time-to-Exhaustion 
 There was no significant interaction of time x training group, F(1,9) = 1.17, P = 
0.31, partial ή2 = 0.115, nor significant main effect of training group, F(1,9) = 0.03, P = 
0.86, nor was there a significant main effect of time F(1,9) = 3.35, P = 0.10, on TE 
measured during aerobic capacity testing in hypobaric hypoxia. Further, there was no 
significant difference of TE in the EXP group between pre-, post-, and follow-up 
assessments in the hypobaric hypoxic chamber, F(2,3) = 3.99, P = 0.11.  
Maximal Oxygen Uptake 
 There was no significant interaction of time x training group, F(1,9) = 2.12, P = 
0.18, partial ή2 = 0.19, nor was there a significant main effect of training group, F(1,9) = 
2.84, P = 0.13. However, there was a significant main effect of time F(1,9) = 22.06, P = 
0.001 for VO2peak as demonstrated by an 11.48% increase from pre- to post-testing 
measures of aerobic capacity testing in hypobaric hypoxia, as is seen in Figure 7. There 
was a significant difference in VO2peak between the three aerobic capacity tests performed 
by the EXP group as further analysis revealed a significant increase of 15.99% from pre- 
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to post-testing, P = 0.03, with no significant difference between the pre- and follow-up 
tests, P = 0.07, nor between the post- and follow-up assessments, P = 0.55. 
Relative Maximal Oxygen Uptake 
 There was no significant interaction of time x training group, F(1,9) = 1.64, P = 
0.23, partial ή2 = 0.15, nor was there a significant main effect of training group, F(1,9) = 
0.61, P = 0.45. However, there was a significant main effect of time F(1,9) = 6.88, P = 
0.03 for RVO2peak as demonstrated by an 11.13% increase from pre- to post-testing 
assessments of aerobic capacity testing in hypobaric hypoxia; however, Further, there 
was no significant difference of RVO2peak in the EXP group between pre-, post-, and 
follow-up assessments in the hypobaric hypoxic chamber, F(2,3) = 6.53, P = 0.06. 
However, while neither reached statistical significance, there was a 14.71% increase from 
the pre- to post-test and a 4.79% decrease from the post-test to the follow-up test, 
resulting in a net gain of 9.21% of RVO2peak. 
4
4.5
5
5.5
6
Pre Post Follow-up
VO2peak  
(L ∙ min-1) 
Time Period 
EXP (n = 6)
CON (n = 5)
Mean (n = 11)
Figure 7. HH peak O2 uptake. * p < .05,  
^ p < .001, indicates a significant main effect of time.  
^ 
* 
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Minute Ventilation 
 There was no significant interaction of time x training group, F(1,9) = 1.23, P = 
0.30, partial ή2 = 0.12, nor a significant main effect of training group, F(1,9) = 4.27, P = 
.07, nor significant main effect of time F(1,9) = 2.21, P = 0.17, on VE measured during 
aerobic capacity testing in hypobaric hypoxia. There was no significant difference of VE 
in the EXP group between pre-, post-, and follow-up aerobic capacity assessments in the 
hypobaric hypoxic chamber, F(2,3) = 5.33, P = 0.053.  
Breathing Frequency 
 There was no significant interaction of time x training group, F(1,9) = 0.18, P = 
0.68, partial ή2 = 0.02, nor a significant main effect of training group, F(1,9) = 0.23, P = 
0.64,  nor was there a significant main effect of time F(1,9) = 0.35, P = 0.57, on f 
measured during aerobic capacity testing in hypobaric hypoxia. Additionally, there was 
no significant difference of f  in the EXP group between pre-, post-, and follow-up 
assessments in the hypobaric hypoxic chamber, F(2,3) = 0.427, P = 0.679. 
34
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Pre Post Follow-up
RVO2peak  
(mL ∙ min-1 ∙ kg-1) 
Time Period 
EXP (n = 6)
CON (n = 5)
Mean (n = 11)
* 
Figure 8. HH relative peak O2 uptake. * p < .05,  
indicates a significant main effect of time.  
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Tidal Volume 
 There was no significant interaction of time x training group, F(1,9) = 0.07, P = 
0.80, partial ή2 = 0.05 nor a significant main effect of training group, F(1,9) = 0.29, P = 
0.65 on VT. However, there was a significant main effect of time on VT, F(1,9) = 7.89, P 
= 0.02, as demonstrated by an increase in VT of 8.75% from pre- to post-assessment of 
aerobic capacity in hypobaric hypoxia. Further, the repeated measures analysis of VT 
during the three testing times for the EXP group displayed a significant difference, F(2,3) 
= 14.59, P = 0.02, and further analysis revealed a significant increase in VT of 10.48% 
from the pre-test to the follow-up test, P < 0.01. 
 
End-tidal Oxygen Pressure 
 There was no significant interaction of time x training group, F(1,9) = 0.02, P = 
0.90, partial ή2 = 0.002, nor significant main effect of training group, F(1,9) = 0.00, P = 
1.00,  nor was there a significant main effect of time F(1,9) = 0.49, P = 0.50, on PetO2 
measured during aerobic capacity testing in hypobaric hypoxia. There was no significant 
difference in PetO2 present in the EXP group between pre-, post-, and follow-up aerobic 
capacity assessments in the hypobaric hypoxic chamber, F(2,3) = 3.59, P = 0.13. 
2.25
2.5
2.75
3
3.25
Pre Post Follow-up
VT  
(L ∙ min-1) 
Time Period 
EXP (n = 6)
CON (n = 5)
Mean (n = 11)
* 
^ 
Figure 9. HH maximal VT. * p < .05, ^ p < .01, indicates 
significant main effect of time. 
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End-tidal Carbon Dioxide Pressure 
 There was no significant interaction of time x training group, F(1,9) = 0.11, P = 
0.75, partial ή2 = 0.01, nor a significant main effect of training groups, F(1,9) = 0.10, P = 
0.77, nor was there a significant main effect of time F(1,9) = 1.18, P = 0.31, on PetCO2 
measured during aerobic capacity testing in hypobaric hypoxia. There was no significant 
difference in PetCO2 present in the EXP group between pre-, post-, and follow-up aerobic 
capacity assessments in the hypobaric hypoxic chamber, F(2,3) = 5.461, P = 0.07. 
Arterial Oxygen Saturation  
 There was a significant, disordinal interaction of time x training group F(1,9) = 
7.71, P = 0.02, partial ή2 = 0.46. Further analysis utilizing a paired samples t-test revealed 
a non-significant, P = 0.18, increase of 2.39%  in SpO2 values for the EXP group and a 
concurrent, significant, P = .03, decrease of 2.72% in SpO2 values for the CON group 
from the pre- to post-testing measurements conducted in the HH chamber. Further, there 
was no significant difference in SpO2 present in the EXP group between pre-, post-, and 
follow-up aerobic capacity assessments in the hypobaric hypoxic chamber, F(2,3) = 
1.733, P = 0.23. 
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Pre Post Follow-up
SpO2 (%) 
Time Period 
EXP (n = 6)
CON (n = 5)
Mean (n = 11)
ǂ 
Figure 10. HH resting SpO2. ǂ p < .05, indicates 
significant interaction of time x training group. Values 
are mean ± SD. 
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Table 8. Hypobaric hypoxia VO2 test parameters 
Variable Group 
Pre-test Post-test 
Mean ± SD 
95% CI 
Lower, Upper Mean ± SD 
95% CI 
Lower, Upper 
HRmax (BPM) EXP 
CON 
Mean 
192.17 ± 4.96 
184.20 ± 8.41 
188.55 ± 7.61 
185.97, 198.37 
177.41, 190.99 
183.59,192.78 
187.00 ± 10.24 
184.60 ± 3.58 
185.91 ± 7.69 
179.62,194.38 
176.51, 192.69 
180.33, 191.28 
TE (min) EXP 
CON 
Mean 
8.96 ± 1.29 
9.06 ± 1.18 
9.01 ± 1.18 
7.82, 10.11 
7.81, 10.32 
8.16, 9.86 
9.62 ± 1.65 
9.23 ± 1.30 
9.45 ± 1.44 
8.23, 10.01 
7.71, 10.75 
8.40, 10.46 
VO2peak  
(L ∙ min -1) 
 
EXP 
CON 
Mean 
4.44 ± .50 
5.20 ± .77 
4.79 ± .72 
3.86, 5.03 
4.56, 5.85 
4.39, 5.26 
5.15 ± .63 
5.58 ± .54 
5.34 ± .61^ 
4.60, 5.70 
4.97, 6.18 
4.95, 5.77 
RVO2peak  
(mL ∙ min-1 ∙ kg-1) 
 
EXP 
CON 
Mean 
34.74 ± 3.86 
37.78 ± 4.90 
36.12 ± 4.42 
30.72, 38.76 
33.38, 42.19 
33.28, 39.24 
39.85 ± 3.01 
40.49 ± 4.99 
40.14 ± 3.82^ 
36.15, 43.56 
36.43, 44.55 
37.42, 42.92 
VE  
(L ∙ min-1) 
EXP 
CON 
Mean 
130.13 ± 18.58 
157.70 ± 26.98 
142.66± 25.91 
109.16, 151.10 
134.73, 180.77 
128.36, 159.46 
140.53 ± 14.98 
159.21 ± 17.15 
149.02 ± 18.03 
125.78, 155.29 
143.04, 175.37 
138.93, 160.82 
VT  
(L ∙ min-1) 
EXP 
CON 
Mean 
2.48 ± .41 
2.81 ± .25 
2.63 ± .37 
2.16, 2.80 
2.46, 3.16 
2.41, 2.88 
2.76 ± .64 
2.98 ± .33 
2.86 ± .51* 
2.28, 3.25 
2.45, 3.51 
2.51, 3.23 
f   EXP 
CON 
Mean 
53.00 ± 6.37 
56.11 ± 8.40 
54.42 ± 7.15 
46.22, 59.78 
48.68, 63.54 
49.53, 59.59 
52.66 ± 9.72 
54.02 ± 8.81 
53.28 ± 8.88 
44.04, 61.27 
44.58, 63.46 
46.95, 59.73 
PetO2  
(mm Hg) 
EXP 
CON 
Mean  
91.39 ± 1.09 
91.33 ± 1.93 
91.36 ± 1.45 
89.98, 97.80 
89.79, 92.88 
90.32, 92.41 
91.64 ± .97 
91.71 ± 1.48 
91.67 ± 1.16 
90.51, 92.77 
90.47, 92.94 
90.84, 92.51 
PetCO2  
(mm Hg) 
EXP 
CON 
Mean 
18.40 ± 1.24 
18.51 ± 2.06 
18.45 ± 1.57 
16.88, 19.93 
16.83, 20.18 
17.32, 19.59 
18.72 ± .62 
19.09 ± 1.68 
18.89 ± 1.17 
17.60, 19.84 
17.86, 20.32 
18.07, 19.73 
SpO2 (%) EXP 
CON 
Mean 
90.67 ± 2.36 
91.80 ± .84 
91.18 ± 1.85 
88.96, 92.37 
89.93, 93.67 
89.97, 62.50 
92.83 ± 1.29ǂ 
89.30 ± 1.30 
91.23 ± 2.22 
91.64, 94.03 
87.99, 90.61 
90.18, 91.96 
N = 11 (EXP, n = 6; CON, n = 5) unless otherwise stated. 
TE, time-to-exhaustion; VO2peak, maximal oxygen uptake; RVO2peak, relative oxygen 
uptake; VE, minute ventilation (BTPS); VT, tidal volume; f, breathing frequency; PetO2, 
end-tidal O2 pressure; PetCO2, end-tidal CO2 pressure. 
* P < .05, ^ P < .01 for difference with Pre-test. 
ǂ P < .05 for significant interaction of time x training group.  
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Table 9. EXP group hypobaric hypoxia VO2 parameters (Mean ± SD) 
Variable Pre-test Post-test Follow-up 
HRmax (BPM) 192.17 ± 4.96 187 ± 10.24 185 ± 10.28 
TE (min) 8.96 ± 1.29 9.62 ± 1.65 9.28 ± 1.91 
VO2peak (L ∙ min 
-1
) 4.44 ± .50 5.15 ± .63* 4.89 ± .61 
RVO2peak (mL ∙ min 
-1
 ∙ kg-1) 34.74 ± 3.86 39.85 ± 3.01 37.94 ± 4.12 
VE (L ∙ min
-1
) 130.13 ± 18.58 140.53 ± 14.98 143.23 ± 10.12 
VT (L ∙ min
-1
) 2.48 ± .41 2.76 ± .64 2.74 ± .44^ 
f   53 ± 6.37 52.66 ± 9.72 53.15 ± 6.89 
PetO2 (mm Hg) 91.39 ± 1.09 91.64 ± .97 92.93 ± .94 
PetCO2 (mm Hg) 18.40 ± 1.24 18.72 ± .62 18.09 ± .73^ 
SpO2 (%) 90.67 ± 2.36 92.83 ± 1.29 91.83 ±1.47 
N = 6 unless otherwise stated. 
TE, time-to-exhaustion; VO2peak, maximal oxygen uptake; RVO2peak, relative oxygen 
uptake; VE, minute ventilation (BTPS); Vt, tidal volume; f, breathing frequency; PetO2, 
end-tidal O2 pressure; PetCO2, end-tidal CO2 pressure.  
* P < .05, ^ P < .01 for difference with Pre-test. 
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CHAPTER V 
 
DISCUSSION 
 The primary findings of the current investigation revealed that NIHT failed to 
elicit significantly greater aerobic endurance performance enhancements in either the NN 
or HH condition when compared to NN endurance training. Further, NIHT did not induce 
significant adaptations of the blood’s O2-carrying capacity compared to endurance 
training in NN. However, the results do suggest that the NIHT protocol induced some 
level of altitude acclimatization via a significant interaction of time and training group as 
evidenced by a simultaneous 2.39% increase and 2.72% decrease in resting SpO2 levels 
measured in HH for the EXP and CON groups, respectively. Additionally, while 
nonsignificant, the EXP group tended to display greater signs of HVR adaptations than 
the CON group as a result of increased VE and VT measurements in the HH chamber.  
Training Intervention 
 There was no significant difference in reported PT training volume performed 
externally and in addition to the intervention training protocol (P = 0.56) between the 
EXP and CON groups, which tends to suggest that any reported differences during the 
post- and follow-up assessments were primarily the result of the differences in the EXP 
and CON endurance training programs. Further, while there was not a significant 
difference in the average distance (km) completed during Week 1, the EXP group 
93 
 
completed significantly fewer km per session during Weeks 2-6, leading to an average of 
13.8 fewer km covered for each EXP participant compared to each CON participant. The 
detriment to training volume brought about by a decrease in O2 availability is often cited 
as an argument against only performing endurance training in hypoxic conditions 
(Dufour et al., 2006; Hoppeler et al., 2008; Ponsot et al., 2006), as is the case with 
traditional altitude training strategies. Additionally, the average SpO2 value recorded 
during each training session of EXP participants was significantly lower (P < .01) at 
82.4% while the CON participants’ average SpO2 was 97.2%. These results indicate that 
the FiO2 of 15% utilized during the NIHT sessions was sufficient to induce hypoxia. As 
the current study only required 3 h of NIHT each week, participants were also able to 
perform higher-intensity training sessions in addition to the intervention protocol. This 
may be advantageous in that the hypoxic stimulus remains supplementary to, and not 
deleterious to total training volume.  
 A potential benefit of NIHT and other discontinuous altitude exposures is the 
reduction of the risk of detrimental BM losses that may occur with extended altitude 
sojourns (Zaccagni et al., 2014). The results of the present study support the reduction of 
such a risk as no significant differences in either BM or BF% were found between the 
EXP and CON groups following the intervention training protocol. However, while prior 
works have reported other prospective detriments of prolonged training camps at higher 
elevations such as sleep disturbances and compromised immune function (Friedmann‐
Bette, 2008; Christopher John Gore et al., 2007; Rusko et al., 2004; Sargent et al., 2013), 
the current investigation did not examine such factors as they relate to NIHT and there 
remains a need for future inquiries in this area. 
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Effects of NIHT on Hematological Parameters 
 No changes in RBC, Hb, Hct, or serum EPO levels were observed following the 
completion of the training intervention; nor were any changes observed after the EXP 
group’s 1 wk detraining period. Thus, the data appear to indicate that the currently 
prescribed NH exposure duration (60 min ∙ d-1 x 3 d ∙ wk-1 x 6 wk) and severity (FiO2 = 
15% or 2750 m) is insufficient to induce any alterations in the aforementioned 
hematological variables. The present results are in agreement with prior works that have 
reported no discernable changes in blood parameters following IHT protocols. While the 
current investigation utilized NH, the majority of HH-based IHT interventions have also 
reported a similar lack of efficacy of IHT to enhance the O2-carrying capacity of blood. 
Prior investigations utilizing IHT protocols ranging in exposure times of 30-90 min ∙ d-1 x 
3-5 d ∙ wk-1 x 3-6 wk and simulated altitudes ranging from 2300-4000 m have reported no 
changes to RBC, Hbcon, and/or Hct levels in highly-trained individuals (Terrados et al., 
1988; Vallier et al., 1996; N. Ventura et al., 2003). However, there is precedence for HH-
based IHT to stimulate hematological alterations. Following a protocol design of 105 min 
∙ d-1 x 10 consecutive days design and HH corresponding to 2500 m, the authors reported 
a significantly elevated Hbcon 2 d after the completion of the intervention, a change not 
correlated to a decreased PV. However, the elevated Hbcon proved short-lived as it 
returned to near baseline levels when participants were tested 1 wk later (Hendriksen & 
Meeuwsen, 2003). 
 In regards to NIHT protocols, the majority of the prior investigations have 
reported no significant alterations in RBC, Hbcon, and/or Hct, nor EPO levels. The NIHT 
exposure durations and simulated altitude severity are wide-ranging in nature, yet are in 
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agreement that the hypoxic stimulus was insufficient to induce hematological 
adaptations. To illustrate, previous studies employing NIHT protocols similar in nature to 
the present investigation and varying from 30-115 min ∙ d-1 x 2-5 d ∙ wk-1 x 4-7 wk and 
FiO2 of 14.5-15.3%, equivalent to elevations of 2500-3000 m, all reported no changes to 
the hematology of participants. Based on the available evidence, it appears the both HH- 
and NH-based IHT interventions have been equally ineffective to induce any 
hematological adaptations often correlated to endurance performance.  
However, factors other than the hypoxic stimulus may be at least partially 
responsible for the lack of any significant changes. For example, the majority of IHT 
protocols utilize training sessions shorter in duration than what has previously been 
recommended as the minimal amount of time of 2 h to stimulate EPO production 
(Eckardt et al., 1989; Hahn & Gore, 2001; Rasmussen et al., 2013). Further, EPO 
production reaches its apex approximately 3-4 d after exposure to the hypoxic stimulus; 
thus, the timing of both the blood draw and the analysis of the hematological parameters 
may be crucial. In the present study, participants’ blood draws were performed 3-5 d after 
their final training session. If any changes were induced via the NIHT protocol, the time 
lag between the final training session and the post-testing blood draw may have proved 
too long for any change to be detected. Finally, it is also possible that current IHT 
practices do not employ a severity of hypoxia adequate to stimulate EPO production 
during the limited exposure times. For example, one of the earlier investigations into 
EPO production stimulation reported that by increasing the simulated altitude from 3000 
m to 4000 m, the time required to elicit significant increases in EPO levels declines from 
114 min to 84 min, respectively (Eckardt et al., 1989). However, the aforementioned 
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study was based on an IHE protocol, and not IHT, highlighting the tradeoff between 
altitude severity and workload intensity that separates IHE and IHT protocols. Therefore, 
if the primary objective is to increase the hematological variables correlated with aerobic 
endurance performance, altitude training strategies employing longer duration exposures 
and/or greater levels of hypoxia, such as LHTL and IHE, may prove more efficacious 
than IHT. 
Effects of NIHT on endurance performance in normobaric normoxia 
 In regards to HRmax during aerobic capacity testing under NN conditions, the 
results of the present investigation are comparable to the majority of previous studies 
reporting no observable changes following IHT. Further, both HH-based (Hendriksen & 
Meeuwsen, 2003; Vallier et al., 1996) and NIHT (Dufour et al., 2006; Roels et al., 2007) 
protocols have failed to elicit adaptations to HRmax during maximal capacity testing. 
However, the effects of IHT on HRmax under NN conditions are far from conclusive. For 
example, it has been previously reported that 6 wk of NIHT was sufficient to lead to 
significant reductions in the HRmax achieved during a VO2max performed on a cycle 
ergometer. However, the same study yielded a statistically stronger reduction in HRmax 
for the NIHT group (P < 0.05) compared to the NN-trained group (P < 0.10), leading the 
authors to proclaim that the reduction in HRmax for the NN-trained group was more of a 
statistical tendency (N. Ventura et al., 2003). Further, it should be noted that each of the 
aforementioned studies utilized trained- to highly-trained individuals, a population in 
which one would not expect to find significant reductions in HRmax after a relatively brief 
(i.e. less than 6 wk), intervention period. Contrarily, it has been well established that a 
reduction in HR after the completion of a training intervention by previously untrained 
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individuals is to be expected due to the added training stimulus. Therefore, it may be 
proposed that if the combination of hypoxia and training volume (intensity x duration) is 
sufficient, it may be possible to elicit similar reductions in HRmax of trained individuals 
following IHT protocols. While the current literature appear to refute such a possibility, 
the work by N. Ventura et al. (2003) demonstrated such an adaptation should not be ruled 
out as of yet. This may be of practical importance as a decreased HRmax could potentially 
indicate an ability to perform submaximal workloads at lower energy costs to the 
individual. 
In the present study, while TE remained unaltered and unaffected by training 
group, both VO2peak (P = 0.01) and RVO2peak (P = 0.03) measured in the NN condition 
increased significantly after the 6 wk training intervention protocol. However, while there 
was no statistically significant difference between training groups (P = 0.093), the CON 
group tended to demonstrate more pronounced increases than the EXP group for both 
VO2peak (7.99 vs. 3.37%) and RVO2peak (7.31 vs. 4.0%). As a result, the findings from the 
current inquiry are in agreement with previous works utilizing trained participants and 
reporting no perceivable effect on endurance performance in NN between hypoxic or 
normoxic training groups. Hendriksen and Meeuwsen (2003), utilizing a cross-over 
design and highly-trained triathletes, reported insignificant improvements in SL VO2max 
of 1.9% and 2.0% after a 9-10 d training intervention in HH and NN, respectively. 
Morton and Cable (2005), employing a 4 wk NIHT protocol of 30 min training sessions 
at the same FiO2 utilized in the present study, 15%, reported a significant 7.2% increase 
in SL VO2max, but no discernable difference between the NIHT and NN training groups. 
Further, a 4 wk NIHT program has previously been shown to improve both VO2max and 
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time-trial cycling performance in elite cyclists in the NN condition, with no significant 
difference between training conditions. Similar to the current study, the aforementioned 
inquiry also allowed participants to complete their regular training agendas in addition to 
the supervised laboratory training sessions (Lecoultre et al., 2010).  
However, not all NIHT protocols have proven effective at improving SL aerobic 
endurance performance. One such inquiry, which utilized trained cyclists and a 30 min ∙ 
d
-1
 x 3 d ∙ wk-1 x 6 wk and simulated altitude equivalent to 3200 m, characteristics that 
are similar in nature to the present investigation, reported no significant change to VO2max 
measured at SL (N. Ventura et al., 2003). Contrary to the aforementioned study, there is 
limited evidence that NIHT may be more effective than normoxic training to improve SL 
aerobic endurance performance at or near SL. Dufour et al. (2006) reported significant 
increases in both VO2max and TE in the NIHT group, but not the NN trained group after a 
6 wk intervention. One potential explanation for the varying efficacy of IHT, whether 
utilizing HH or NH, appears to be the training volume performed under hypoxia. The 
implementation of various training intensities and hypoxic severities may prove vital in 
the outcome of IHT practices to improve aerobic endurance performance at SL and low 
altitudes. 
Another interesting finding from the current investigation is the change seen in 
maximal ventilatory properties during aerobic capacity testing at SL. Maximal VE during 
NN post-testing revealed a significant interaction (P < .05) of time x training group as 
demonstrated by a 9.15% increase in VE for the CON group and a concurrent 3.92% 
decrease in VE for the EXP group. The current results are in direct contrast to prior works 
reporting no changes of maximal VE measured in NN following an either an NIHT 
99 
 
protocol (Dufour et al., 2006; Lecoultre et al., 2010; N. Ventura et al., 2003) or an HH-
based IHT protocol (Vallier et al., 1996). Further, the present results represent a more 
drastic departure from previously reported alterations in resting ventilatory parameters. 
Katayama et al. (2000) reported a slight, insignificant increase in HVR at rest following 
IHT and a significant decline in HVR for the NN training group. Yet, there is one inquiry 
in which maximal VE alterations similar to the current study were reported. Roels et al. 
(2007) reported an insignificant 9% increase of maximal VE under NN testing conditions 
for the NN-trained group with virtually no change reported in the experimental group 
following a 3 wk NIHT protocol.  
A potential explanation for the observed changes in VE may be the result of 
alterations to f during testing. While insignificant, the results of the current study indicate 
a 7.79% decrease and simultaneous 2.69% increase in f for the EXP and CON groups, 
respectively. Further, VT appears unlikely to have had such an influence as similar 
increases in VT of 4.03% and 5.96% occurred in the EXP and CON groups, respectively. 
Adding to the intrigue of the is the similarity between the other ventilatory parameters, 
including PetO2 and PetCO2, neither of which were shown to be greatly impacted by the 
change in VE. While Katayama et al. (1999) also reported no alterations in either PetO2 or 
PetCO2, their measurements were performed at rest and the results of the current study 
were obtained at the time VO2peak was reached. However, together, these results may 
indicate that IHT does not impact such variables at rest nor during exercise, yet more 
evidence is needed before any conclusions may be drawn. The HVR typically results in 
the onset of hyperventilation to offset the reduction in PO2, such a response to hypoxic 
conditions may potentially be detrimental to SL performance due to the increased energy 
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demands of respiration during high intensity exercise. However, the current results 
appear to indicate the opposite of the accepted rationale. It remains unclear what led to 
such a striking divergence from the accepted logic regarding ventilatory adaptations, thus 
future studies utilizing similar training protocols are warranted to either support or refute 
the current findings.  
Effects of NIHT on endurance performance in hypobaric hypoxia 
 A primary interest of the current investigation was whether or not the prescribed 
NIHT protocol was adequate to induce significant alterations in aerobic performance 
parameters measured in an HH setting equivalent to an altitude of 3033 m (10,000 ft). 
Demonstrating the need for effective acclimatization methods, not only to present or 
reduce cases of high-altitude illnesses, but also to restore the endurance performance 
capabilities that are often lost upon acute altitude exposure. To that point, the current 
study revealed a 41.5% decrease in mean RVO2max from the NN to the HH condition 
during pre-testing and a 38.27% decrement during post-testing. While the aforementioned 
results indicate a greater decrement than what has previously been reported (Peter 
Bärtsch & Gibbs, 2007; M Burtscher et al., 2006; Chapman et al., 1999; Muza, 2007), the 
individual variability that has been documented (Chapman, 2013) as well as the fact that 
hypoxia has been reported to lead to greater aerobic capacity detriments in trained than 
untrained individuals (Raphael Faiss et al., 2014). Therefore, exploring potential methods 
to induce acclimatization and offset such declines are of great importance to military 
personnel (Krueger, 1993; Muza, 2007).  
 HRmax remained unaltered for either group following the intervention protocol and 
the current findings are in agreement with the majority of prior studies indicating IHT 
101 
 
protocols are insufficient to induce such changes during acute hypoxic exposures 
(Beidleman et al., 2014; Dufour et al., 2006; Geiser et al., 2001; Hendriksen & 
Meeuwsen, 2003; Ofner et al., 2014). Although HRmax showed no sign of change 
following the training intervention, there was still a significant (P < 0.01) decline in mean 
HRmax  of 4.09% and 5.53% during pre- and post-testing, respectively, from the NN to the 
HH conditions. Further, the current results are in agreement with previous work (Pascal 
Mollard et al., 2007).  
 Although there were no statistically significant changes in TE to report, the 
interaction’s partial ή2 value of 0.12 revealed a moderate effect size, thus, the potential 
for practical implications. While the mean TE only slightly improved, more marked 
differences between training groups were observed. Again, while not statistically 
significant, the EXP group’s TE increased by 7.37% from pre- to post-testing, whereas 
the CON group only increased TE by 1.88%. The EXP group’s increase represents an 
increase of approximately 40 s for TE in an HH setting, which would appear to have 
practical significance. As combat operations have been reported to consist of endurance 
activities of varying intensity levels (Henning et al., 2011), an increase in TE of 40 s 
during maximal exercise may provide the difference between success and failure of a 
mission. 
 Analogous to the observed aerobic capacity changes in NN, both VO2peak (P < 
0.01) and RVO2peak (P < 0.05) significantly improved following the intervention training 
period. However, neither VO2peak nor RVO2peak revealed a statistically significant 
interaction or main effect of training group. Yet, based on the reported partial ή2 value of 
0.19, the results tend to indicate a difference that may be of practical significance. In the 
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present study, the VO2peak achieved by the EXP group increased by 15.99%, whereas the 
CON only demonstrated an increase of 7.31%. In a similar fashion, RVO2peak of the EXP 
group increased by 14.71% compared to only a 7.17% increase in the CON group. As the 
EXP group demonstrated increases in O2 uptake more than twice the level of increase 
achieved by the CON group, the practical significance, partial ή2 = 0.15, may indeed 
outweigh the lack of statistical significance, which is potentially a result of the low 
number of participants rather than the measured changes. The current findings are in 
agreement with the limited number of previous NIHT studies that reported significant 
improvements of aerobic performance under hypoxic conditions, yet no discernable 
differences between the control and experimental groups (Roels et al., 2007; N. Ventura 
et al., 2003). Further, prior works utilizing HH-based IHT protocols have also 
demonstrated equivocal aerobic performance outcomes under hypoxic conditions as some 
have reported significant enhancements (Roskamm et al., 1969; Terrados et al., 1988) 
while more recent works have reported no performance differences between the IHT and 
control groups (Holliss et al., 2014). The literature as it relates to LHTL strategies to 
improve hypoxic endurance performance is not only scarce, but also equivocal as 
previous studies have reported significant improvements in such parameters (Schuler et 
al., 2007) while others have failed to do so (Siebenmann et al., 2012).  The ambivalent 
nature of altitude training strategies, excluding LHTH, to improve performance at 
altitude, may be due to the high degree of variability present in methodologies as 
differences such as the use of a control group, exposure duration, and exposure severity 
remain. While the available literature as it relates to IHT and subsequent VO2max 
performance during hypoxic conditions remains somewhat limited (Muza, 2007; Roels et 
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al., 2007) and therefore difficult to formulate any concrete assumptions as to its efficacy, 
the aforementioned works and the findings from the present study appear to provide 
justification for continued research efforts in this area.   
 In terms of the ventilatory parameters during maximal exercise in the HH setting, 
an interesting pattern emerged, which may suggest a somewhat enhanced HVR for the 
EXP compared to the CON group. Similar to some of the aforementioned variables, 
maximal VE did not reach statistical significance following the intervention period; 
however, based on the moderate effect size, partial ή2 = 0.12, there is some evidence of 
practical significance for an elevated ventilatory response in the EXP group compared to 
the CON group. This is demonstrated by a 7.99% increase in VE for the EXP group with 
only a 0.95% increase in VE measured in the CON group. This alteration was most likely 
the result of the changes in VT rather than f, as the former displayed a significant increase 
(P < 0.05) from pre- to post-assessments, while the latter revealed negligible changes. 
Further, and the likely cause of the discrepancy in VE between training groups were the 
increases in VT of 11.29% and 6.05% for the EXP and CON groups, respectively. This 
would appear to indicate that the EXP participants were able to take deeper breaths 
during maximal effort exercise in acute hypoxia.  
 The current results represent a direct contrast to what has been previously 
reported as multiple investigations detailed decreased VT and increased f during hypoxic 
exposures. Further, each of these works examined the difference in physiological 
responses to NH compared to HH during rest, indicating both the decrease in VT and 
increase in f are intensified by HH compared to NH. These varied responses have led to 
the acceptance that, in terms of simulated altitude, HH is preferable to NH to induce 
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acclimatization (Raphael Faiss et al., 2013; Loeppky et al., 1997; Savourey et al., 2003). 
Additional studies have examined the alterations in ventilatory parameters during 
exercise and reported that the same trends revealed during resting conditions tend to be 
exaggerated during submaximal exercise (Engelen et al., 1996; Mateika & Duffin, 1994), 
yet not during maximal exertion (Stang et al., 2014). The ventilatory adaptations 
observed in the present investigation are of particular interest for two specific reasons. 
First, the cause of the increase in VE during the current study is likely an increase in VT 
and not f, which is in direct contrast to previously reported results. This is of potential 
importance as it may indicate deeper breaths being taken, theoretically allowing greater 
time for O2 extraction. However, based on PetO2 and PetCO2 measurements in the 
current study, this claim cannot be substantiated and therefore, additional examinations of 
this question appear warranted. Second, there may be some indication that NIHT 
potentially elicits physiological adaptations that transfer to an HH setting. Resting SpO2 
measurements revealed an interaction of both statistical (P < .05) and practical 
significance (partial ή2 = 0.46) following the 6 wk intervention protocol. This interaction 
was exhibited via a 2.38% increase (P = 0.18) and 2.72% decrease (P = 0.03) in SpO2 
measured in the HH condition for the EXP and CON groups, respectively. As decreased 
SaO2 levels have previously been shown to reduce endurance performance capabilities 
(Amann & Calbet, 2008; Calbet et al., 2003a; Pascal Mollard et al., 2007), increases to 
resting SaO2 levels may potentially and positively impact endurance performance in 
hypoxic conditions. Although it should be noted that increasing SaO2 levels in and of 
itself will not restore aerobic capacity to SL values (Calbet et al., 2003b), increases in 
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such physiological variables may still be encouraging indications of the potential ability 
of NIHT to induce acclimatization. 
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CHAPTER VI 
 
CONCLUSION 
Limitations 
 The current investigation utilized trained, male ROTC Cadets as participants. Our 
primary incentive for the use of said participants was to potentially increase the 
applicability of our results to military personnel that may be required to deploy to high-
altitude locations without the benefit of a sufficient acclimatization period. However, as a 
result of the stringent inclusion criteria, the potential for a sufficient sample size, in terms 
of statistical power, to reduce the risk of Type II errors was compromised. To this point, 
none of the interactions achieved a β > 0.26. Further discussion of this study’s limitations 
and delimitations may be found on pages 13-14. 
Conclusions 
 The present study was designed to examine the hypothesis that a 6 wk NIHT 
protocol would elicit significant aerobic capacity enhancements and that these 
improvements would be greater in the EXP group compared to the CON group. A 
secondary aim was to determine if the prescribed intervention would be sufficient to 
induce hematological adaptations typically associated with aerobic performance. In terms 
of the latter, this hypothesis was not supported in this inquiry. In terms of the former, 
while there may have not been statistically significant results to support this hypothesis, 
some trends did emerge that may be of practical 
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importance. First, despite no significant differences in TE measured in the HH condition, 
EXP participants tended to display greater increases compared to their CON counterparts. 
In fact, EXP participants increased their TE by approximately 40 s, whereas the CON 
participants only increased TE by approximately 10 s. Further, while the mean VO2peak 
and mean RVO2peak both revealed significant increases from pre- to post-testing in the 
HH chamber, the EXP group demonstrated percentage increases that were more than 
twice that of the CON group. It should be noted that both groups displayed significantly 
greater aerobic capacity measures in the NN testing condition as well, but with more 
regularity of improvement between the training groups. Therefore, this may potentially 
indicate the NIHT protocol was somewhat, although not statistically, effective to improve 
endurance performance under hypoxic conditions. Finally, the EXP group displayed 
some tendencies that may indicate some form of ventilatory adaptation. The combination 
of a significantly reduced VE during maximal exercise in the NN condition and the 
significant increase of SpO2, as well as the tendency for an increased VT during the 
hypoxic testing condition displayed by the EXP group may denote more efficient 
breathing during maximal exercise in both NN and HH settings following the NIHT 
protocol. To the authors’ knowledge, this is the first study to examine the efficacy of 
endurance training in NH to improve aerobic endurance performance in HH utilizing 
trained ROTC cadets. The aforementioned improvements in aerobic capacity may have 
substantial performance and injury risk implications during military operations in high-
altitude locations. Given the significance of aerobic capacity to sustain moderate intensity 
efforts as well as recover from bouts of maximal exertion, the decrements hypoxia poses 
to both the former and the latter are of great practical and functional importance for 
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present day military operations. Further, as military personnel operating in mountainous 
regions are already functioning near their VO2max genetic ceiling, any enhancements may 
literally prove to be the difference between life and death. Due to the perceived potential 
for NIHT to improve endurance performance during acute hypoxic exposure, as well as 
the tremendous risks undertaken during combat operations, research efforts in this area 
must continue in an attempt to determine the ideal acclimatization strategy or strategies. 
Future Investigations 
 The current investigation provides additional understandings of the potential 
effects of intermittent hypoxic training strategies to improve aerobic endurance 
performance in HH settings. Specifically, the potential for the utilization of NIHT to 
elicit endurance performance enhancements during acute exposure to an HH condition. 
While there are noted differences in the physiological responses to NH and HH, there are 
a limited number of investigations that have utilized the former for IHT sessions while 
testing in the latter. Further, the current findings displayed some signs of acclimatization 
related to the HVR, but not in regards to hematological changes related to blood’s O2-
carrying capacity. Therefore, keeping in mind the generally lower costs (financial, ease of 
access, etc.) of NH compared to HH, further studies appear warranted. In particular, 
future research should seek to expand upon the currently available evidence related to the 
NIHT dosage necessary to elicit physiological changes related to altitude acclimatization. 
Additionally, prospective studies should seek to expand upon the existing evidence 
regarding the potential for the use of NIHT to enhance aerobic and anaerobic 
performance in both acute and extended altitude exposures. 
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APPENDIX A 
 
RESEARCH DESIGN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R
ecru
itm
en
t 
EXP: IHT (FiO2 = 15%) 
CON: Normoxia (FiO2 = 20.9%) 
Post-test 
Training Protocol 
1 h ∙ d-1 x 3 d ∙ wk-1 x 6 wk 
Pre-test 
EXP: 
Detraining  
(1 wk) 
CON: 
Participation 
Complete 
Follow-up 
test 
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APPENDIX B 
 
NORMOBARIC NORMOXIA VO2max TESTING SETUP 
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APPENDIX C 
 
HYPOBARIC HYPOXIA VO2max TESTING SETUP 
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APPENDIX D 
 
PRE-EXERCISE TESTING HEALTH & EXERCISE STATUS QUESTIONNAIRE 
 
 
 
 
Name _____________________________________________ Date______________ 
 
Work Phone __________________ Home Phone (Cell)________________________ 
 
E-mail address________________________ Preferred method of contact: Call, email, or 
text 
 
Person to contact in case of emergency________________________________ 
 
Emergency Contact Phone ______________________  
 
Gender ________ Age ______(yrs) Height ______ (ft)______(in) 
Weight______(lbs) 
 
Does the above weight indicate:  a gain____   a loss____   no change____   in the past 
year? 
 
If a change, how many pounds?___________(lbs) 
 
A. JOINT-MUSCLE STATUS (Check areas where you currently have problems) 
 
 Joint Areas      Muscle Areas 
 (    )  Wrists      (    )  Arms 
 (    )  Elbows      (    )  Shoulders 
 (    )  Shoulders      (    )  Chest 
 (    )  Upper Spine & Neck    (    )  Upper Back & Neck 
 (    )  Lower Spine     (    )  Abdominal Regions 
 (    )  Hips      (    )  Lower Back 
 (    )  Knees      (    )  Buttocks 
 (    )  Ankles      (    )  Thighs 
 (    )  Feet      (    )  Lower Leg 
 (    )  Other_______________________   (    )  Feet 
        (   )Other__________________ 
 
B.   HEALTH STATUS (Check if you currently have any of the following 
conditions) 
 
(    )  High Blood Pressure   (    )  Acute Infection 
(    )  Heart Disease or Dysfunction  (    )  Diabetes or Blood Sugar Level 
Abnormality 
(    )  Peripheral Circulatory Disorder  (    )  Anemia 
(    )  Lung Disease or Dysfunction  (    )  Hernias 
(    )  Arthritis or Gout    (    )  Thyroid Dysfunction 
(    )  Edema     (    )  Pancreas Dysfunction 
RECRUITMENT NO.______________ 
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(    )  Epilepsy     (    )  Liver Dysfunction 
(    )  Multiply Sclerosis    (    )  Kidney Dysfunction 
(    )  High Blood Cholesterol or   (    )  Phenylketonuria (PKU)  
(    )  Triglyceride Levels   (    )  Loss of Consciousness    
(    )  Allergic reactions to rubbing alcohol 
 C.   PHYSICAL EXAMINATION HISTORY 
 Approximate date of your last physical examination __________________  
  
 Physical problems noted at that time __________________________ 
 
 Has a physician ever made any recommendations relative to limiting your level of 
 physical exertion? _________YES __________NO 
 If YES, what limitations were recommended? 
 ____________________________________________________________ 
 
D.   CURRENT MEDICATION USAGE (List the drug name and the condition being 
managed) 
 
 MEDICATION      CONDITION 
__________________________  ____________________________________ 
__________________________  ____________________________________ 
__________________________  ____________________________________ 
 
E.   PHYSICAL PERCEPTIONS (Indicate any unusual sensations or perceptions.   
 Check if you have recently experienced any of the following during or soon after  
 physical activity (PA); or during sedentary periods (SED)) 
PA SED     PA SED 
(    ) (    )  Chest Pain   (    ) (    )  Nausea 
(    ) (    )  Heart Palpitations   (    ) (    )  Light Headedness 
(    ) (    )  Unusually Rapid Breathing (    ) (    )  Loss of Consciousness 
(    ) (    )  Overheating   (    ) (    )  Loss of Balance 
(    ) (    )  Muscle Cramping   (    ) (    )  Loss of Coordination 
(    ) (    )  Muscle Pain   (    ) (    )  Extreme Weakness 
(    ) (    )  Joint Pain    (    ) (    )  Numbness 
(    ) (    )  Other_______________________ (    ) (    )  Mental Confusion 
 
F. FAMILY HISTORY (Check if any of your blood relatives . . . parents, brothers,  
 sisters, aunts, uncles, and/or grandparents . . . have or had any of the following) 
 (    )  Heart Disease 
 (    )  Heart Attacks or Strokes (prior to age 50) 
 (    )  Elevated Blood Cholesterol or Triglyceride Levels 
 (    )  High Blood Pressure 
 (    )  Diabetes 
 (    )  Sudden Death (other than accidental) 
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G. EXERCISE STATUS 
Do you regularly engage in aerobic forms of exercise (i.e., jogging, cycling, walking, etc.)?    
 YES        NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 Do you regularly lift weights?           
 YES        NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
 Do you regularly play recreational sports (i.e., basketball, racquetball, volleyball,  
 etc.)?    
 YES        NO 
How long have you engaged in this form of exercise?  ______ years ______ months 
How many hours per week do you spend for this type of exercise?  _______ hours 
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APPENDIX E 
 
IRB APPROVAL 
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APPENDIX F 
 
INFORMED CONSENT FORM 
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APPENDIX G 
 
RECRUITMENT SCRIPT 
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